Xperi Holding 10-Q 9 May 22 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	Apr. 25, 2022
Cover [Abstract]
Entity Registrant Name	XPERI HOLDING CORPORATION
Trading Symbol	XPER
Entity Central Index Key	0001803696
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Document Type	10-Q
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		103,950,742
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity File Number	001-39304
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-4734590
Entity Address, Address Line One	3025 Orchard Parkway
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	321-6000
Document Quarterly Report	true
Document Transition Report	false
Security12b Title	Common Stock (par value $0.001 per share)
Security Exchange Name	NASDAQ

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue:	$ 257,420	$ 221,596
Operating expenses:
Cost of revenue, excluding depreciation and amortization of intangible assets	27,697	28,132
Research, development and other related costs	59,370	55,223
Selling, general and administrative	70,446	67,430
Depreciation expense	5,866	5,684
Amortization expense	39,319	52,195
Litigation expense	1,753	2,533
Total operating expenses	204,451	211,197
Operating income	52,969	10,399
Interest expense	(8,429)	(11,313)
Other income (expense), net	968	1,425
Income before taxes	45,508	511
Provision for (benefit from) income taxes	21,533	(4,015)
Net income	23,975	4,526
Less: net loss attributable to noncontrolling interest	(968)	(761)
Net income attributable to the Company	$ 24,943	$ 5,287
Income per share attributable to the Company:
Basic	$ 0.24	$ 0.05
Diluted	$ 0.24	$ 0.05
Weighted average number of shares used in per share calculations-basic	103,679	104,940
Weighted average number of shares used in per share calculations-diluted	105,332	107,776

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 23,975	$ 4,526
Other comprehensive loss, net of tax:
Change in foreign currency translation adjustment	(892)	(1,045)
Net unrealized loss on available-for-sale debt securities	(122)	(34)
Other comprehensive loss, net of tax	(1,014)	(1,079)
Comprehensive income	22,961	3,447
Less: comprehensive loss attributable to noncontrolling interest	(968)	(761)
Comprehensive income attributable to the Company	$ 23,929	$ 4,208

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents		$ 214,095	$ 201,121
Available-for-sale debt securities		52,720	60,534
Accounts receivable, net of allowance for credit losses of $2,895 and $3,012, respectively		100,203	143,683
Unbilled contracts receivable, net	[1]	121,778	77,677
Other current assets		42,737	36,459
Total current assets		531,533	519,474
Long-term unbilled contracts receivable	[2]	43,112	4,107
Property and equipment, net		59,251	60,974
Operating lease right-of-use assets		65,513	68,498
Intangible assets, net		778,680	817,916
Goodwill		850,100	851,088
Other long-term assets		150,641	147,965
Total assets		2,478,830	2,470,022
Current liabilities:
Accounts payable		11,835	7,811
Accrued liabilities		99,540	110,705
Current portion of long-term debt, net		36,152	36,095
Deferred revenue		48,913	35,136
Total current liabilities		196,440	189,747
Deferred revenue, less current portion		34,128	37,107
Long-term deferred tax liabilities		19,085	19,848
Long-term debt, net		720,333	729,392
Noncurrent operating lease liabilities		51,930	54,658
Other long-term liabilities		102,267	98,842
Total liabilities		1,124,183	1,129,594
Commitments and contingencies (Note 15)
Company stockholders’ equity:
Preferred stock: $0.001 par value; (2022: authorized 15,000 shares; 2021: authorized 15,000 shares; and no shares issued and outstanding)
Common stock: $0.001 par value; (2022: authorized 350,000 shares, issued 115,647 shares, outstanding 103,921 shares; 2021: authorized 350,000 shares, issued 113,460, outstanding 103,260 shares)		116	113
Additional paid-in capital		1,365,277	1,340,480
Treasury stock at cost (2022: 11,726 shares; 2021: 10,200 shares)		(206,350)	(178,022)
Accumulated other comprehensive loss		(1,766)	(752)
Retained earnings		207,539	187,814
Total Company stockholders’ equity		1,364,816	1,349,633
Noncontrolling interest		(10,169)	(9,205)
Total equity		1,354,647	1,340,428
Total liabilities and equity		$ 2,478,830	$ 2,470,022
[1]	The unbilled contracts receivable increase relates primarily to a change in billing process in the three months ended March 31, 2022. This change has no impact on the Company’s cash flows.
[2]	The long-term unbilled contracts receivable increase relates primarily to the recognition of revenue from a multi-year contract with a customer in the three months ended March 31, 2022.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Accounts receivable allowance for credit losses	$ 2,895	$ 3,012
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	15,000,000	15,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	350,000,000	350,000,000
Common stock, shares issued (in shares)	115,647,000	113,460,000
Common stock, shares outstanding (in shares)	103,921,000	103,260,000
Treasury stock, shares (in shares)	11,726,000	10,200,000

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 23,975	$ 4,526
Adjustments to reconcile net income to net cash from operating activities:
Depreciation of property and equipment	5,866	5,684
Amortization of intangible assets	39,319	52,195
Stock-based compensation expense	16,804	13,219
Deferred income taxes	(911)	666
Other	1,984	3,217
Changes in operating assets and liabilities:
Accounts receivable	43,698	(7,632)
Unbilled contracts receivable	(82,995)	2,295
Other assets	(8,806)	(10,697)
Accounts payable	4,024	11,429
Accrued and other liabilities	(7,483)	(45,687)
Deferred revenue	10,798	(2,486)
Net cash from operating activities	46,273	26,729
Cash flows from investing activities:
Purchases of property and equipment	(4,289)	(1,772)
Proceeds from sale of property and equipment	0	5
Purchases of intangible assets	(180)	(36)
Purchases of short-term investments	(4,490)	(42,505)
Proceeds from sales of investments	2,000	16,921
Proceeds from maturities of investments	10,023	10,000
Net cash from investing activities	3,064	(17,387)
Cash flows from financing activities:
Dividends paid	(5,218)	(5,264)
Repayment of debt	(10,125)	(13,125)
Proceeds from employee stock purchase program and exercise of stock options	8,000	6,715
Repurchases of common stock	(28,328)	(32,359)
Net cash from financing activities	(35,671)	(44,033)
Effect of exchange rate changes on cash and cash equivalents	(692)	(738)
Net increase (decrease) in cash and cash equivalents	12,974	(35,429)
Cash and cash equivalents at beginning of period	201,121	170,188
Cash and cash equivalents at end of period	214,095	134,759
Supplemental disclosure of cash flow information:
Interest paid	7,188	9,015
Income taxes paid, net of refunds	$ 3,334	$ 5,921

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interest
Beginning balance at Dec. 31, 2020	$ 1,451,119	$ 110	$ 1,268,471	$ (77,218)	$ 1,264	$ 264,250	$ (5,758)
Beginning balance (in shares) at Dec. 31, 2020		104,775		5,407
Issuance of subsidiary shares to noncontrolling interest			(3)				3
Net income (loss)	4,526					5,287	(761)
Other comprehensive loss	(1,079)				(1,079)
Cash dividends paid on common stock	(5,264)					(5,264)
Issuance of common stock in connection with exercise of stock options	228		228
Issuance of common stock in connection with exercise of stock options (in shares)		12
Issuance of common stock in connection with employee stock purchase plan	6,486	$ 1	6,485
Issuance of common stock in connection with employee stock purchase plan (in shares)		633
Issuance of restricted stock, net of shares canceled	1	$ 1
Issuance of restricted stock, net of shares canceled (in shares)		873
Repurchases of common stock, shares exchanged	(7,352)			$ (7,352)
Repurchases of common stock, shares exchanged (in shares)		(347)		347
Repurchases of common stock	(25,007)			$ (25,007)
Repurchases of common stock, (in shares)		(1,071)		1,071
Stock-based compensation expense	13,219		13,219
Ending balance at Mar. 31, 2021	1,436,877	$ 112	1,288,400	$ (109,577)	185	264,273	(6,516)
Ending balance (in shares) at Mar. 31, 2021		104,875		6,825
Beginning balance at Dec. 31, 2021	1,340,428	$ 113	1,340,480	$ (178,022)	(752)	187,814	(9,205)
Beginning balance (in shares) at Dec. 31, 2021		103,260		10,200
Issuance of subsidiary shares to noncontrolling interest			(4)				4
Net income (loss)	23,975					24,943	(968)
Other comprehensive loss	(1,014)				(1,014)
Cash dividends paid on common stock	(5,218)					(5,218)
Issuance of common stock in connection with exercise of stock options	4		4
Issuance of common stock in connection with exercise of stock options (in shares)		1
Issuance of common stock in connection with employee stock purchase plan	7,994	$ 1	7,993
Issuance of common stock in connection with employee stock purchase plan (in shares)		739
Issuance of restricted stock, net of shares canceled	2	$ 2
Issuance of restricted stock, net of shares canceled (in shares)		1,609
Repurchases of common stock, shares exchanged	(11,068)			$ (11,068)
Repurchases of common stock, shares exchanged (in shares)		(659)		659
Shares exchanged and returned to assumed plans				(162)
Repurchases of common stock	(17,260)			$ (17,260)
Repurchases of common stock, (in shares)		(1,029)		1,029
Stock-based compensation expense	16,804		16,804
Ending balance at Mar. 31, 2022	$ 1,354,647	$ 116	$ 1,365,277	$ (206,350)	$ (1,766)	$ 207,539	$ (10,169)
Ending balance (in shares) at Mar. 31, 2022		103,921		11,726

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement Of Stockholders Equity [Abstract]
Cash dividends paid on common stock, price per share	$ 0.05	$ 0.05

The Company and Basis of Presen

The Company and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
The Company and Basis of Presentation	NOTE 1 – THE COMPANY AND BASIS OF PRESENTATION On December 18, 2019, Xperi Corporation (“Xperi”) entered into an Agreement and Plan of Merger and Reorganization with TiVo Corporation (“TiVo”) to combine in an all-stock merger of equals transaction (the “Mergers”). Immediately following the consummation of the Mergers on June 1, 2020, (the “Merger Date”), Xperi Holding Corporation (the “Company”), a Delaware corporation founded in December 2019 under the name “XRAY-TWOLF HoldCo Corporation,” became the parent company of both Xperi and TiVo. The common stock of Xperi and TiVo were de-registered after completion of the Mergers. On June 2, 2020, Xperi Holding Corporation’s common stock, par value $0.001 per share, commenced trading on the Nasdaq Global Select Market (“Nasdaq”) under the ticker symbol “XPER.” Xperi Holding Corporation is a leading consumer and entertainment product/solutions licensing company and one of the industry’s largest intellectual property licensing platforms, with a diverse portfolio of media and semiconductor intellectual property and more than 11,000 patents and patent applications worldwide. The Company creates extraordinary experiences at home and on the go for millions of consumers around the world, elevating content and how audiences connect with it in a way that is more intelligent, immersive and personal. Powering smart devices, connected cars, entertainment experiences and more, the Company has created a unified ecosystem that reaches highly engaged consumers, uncovering significant new business opportunities, now and in the future. The Company’s technologies are integrated into billions of consumer devices, media platforms, and semiconductors worldwide, driving increased value for partners, customers and consumers. The accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles (“GAAP”) in the United States (“U.S.”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. The amounts as of December 31, 2021 have been derived from the Company’s annual audited financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 24, 2022 (the “Form 10-K”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary (consisting of normal recurring adjustments) to state fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These financial statements should be read in conjunction with the annual audited financial statements and notes thereto as of and for the year ended December 31, 2021, included in the Form 10-K. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022 or any future period and the Company makes no representations related thereto. In the fourth quarter of 2018, the Company funded a new subsidiary, Perceive Corporation (“Perceive”), which was created to focus on delivering edge inference solutions. As of March 31, 2022, the Company’s ownership interest in Perceive was approximately 80%. The operating results of Perceive have been consolidated in the Company’s condensed consolidated financial statements for all periods presented. The Company is currently planning, subject to any required regulatory approvals, a separation of the Company’s product business and IP licensing business through a tax-efficient transaction, resulting in two independent, publicly traded companies. The Company continues to evaluate the optimal timing of the contemplated business separation and currently anticipates that such separation will be completed in the second half of 2022. Reclassification Certain reclassifications have been made to prior period balances in order to conform to the current period’s presentation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES There have been no significant changes in the Company’s significant accounting policies during the three months ended March 31, 2022, as compared to the significant accounting policies described in the Form 10-K. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, challenging, and subjective judgment include the estimation of licensees’ quarterly royalties prior to receiving the royalty reports, the determination of stand-alone selling price and the transaction price in an arrangement with multiple performance obligations, the estimation of variable consideration, the assessment of the recoverability of goodwill, the assessment of useful lives and recoverability of other intangible assets and long-lived assets, recognition and measurement of current and deferred income tax assets and liabilities, the assessment of unrecognized tax benefits, and purchase accounting resulting from business combinations, among others. Actual results experienced by the Company may differ from management’s estimates. The COVID-19 pandemic has resulted in a global slowdown of economic activity which has reduced demand for a broad variety of goods and services, while disrupting sales channels, marketing activities and supply chains. The Company’s business operations have been negatively impacted by the COVID-19 pandemic and related events, and the Company expects this disruption may continue to have a negative impact on its revenue and results of operations, especially in light of the spread of the highly transmissible BA.2 Omicron subvariant and potential new variants that may arise in the future. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is currently uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures; the continuing disruption of the global supply chain affecting the Company’s industry; and the impact of the pandemic on the global economy and demand for consumer products. The impact of the COVID-19 pandemic and related events, including actions taken by various government authorities in response, have increased market volatility and make the estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes more difficult. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require it to update its estimates, judgments or revise the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Recent Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting

Revenue

Revenue	3 Months Ended
	Mar. 31, 2022
Revenue From Contract With Customer [Abstract]
Revenue	NOTE 3 – REVENUE Revenue Recognition General Revenue is recognized when control of the promised goods or services is transferred to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services, which may include various combinations of goods and services which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of sales taxes collected from customers which are subsequently remitted to governmental authorities. In situations where foreign withholding taxes are withheld by the Company’s licensee, revenue is recognized gross of withholding taxes that are remitted directly by the licensee to a local tax authority. Some of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are separately accounted for if they are distinct. In an arrangement with multiple performance obligations, the transaction price is allocated among the separate performance obligations on a relative stand-alone selling price basis. The determination of stand-alone selling price considers market conditions, the size and scope of the contract, customer and geographic information, and other factors. When observable prices are not available, stand-alone selling price for separate performance obligations is based on the cost-plus-margin approach, considering overall pricing objectives. The allocation of transaction price among performance obligations in a contract may impact the amount and timing of revenue recognized in the Condensed Consolidated Statements of Operations during a given period. When a contract with a customer includes a variable transaction price, an estimate of the consideration which the Company expects to be entitled to for transferring the promised goods or services is made at contract inception. The amount of variable consideration is estimated at contract inception by considering all available information (historical, current and forecast) at the time and updated as additional information becomes available. The estimate of variable consideration is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Subsequent changes in the transaction price resulting from changes in the estimate of variable consideration are allocated to the performance obligations in the contract on the same basis as at contract inception. When variable consideration is in the form of a sales-based or usage-based royalty in exchange for a license of IP, or when a license of IP is the predominant item to which the variable consideration relates, revenue is recognized at the later of when the subsequent sale or usage occurs or the performance obligation to which some or all of the sales-based or usage-based royalty has been allocated has been satisfied or partially satisfied. Description of Revenue-Generating Activities The Company operates in two business segments. In its IP Licensing segment, the Company licenses its innovations to leading companies in the broader entertainment and semiconductor industries, and those developing new technologies that will help drive the industries forward. Licensing arrangements include access to one or more of the Company’s foundational patent portfolios and may also include access to some of its industry-leading technologies and proven know-how. In its Product segment, the Company derives the majority of its revenue from licensing its technology to customers primarily through Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology. IP License Arrangements In its IP Licensing segment, the Company licenses (i) its media patent portfolios (“Media IP licensing”) to multichannel video programming distributors, over-the-top video service providers, consumer electronics manufacturers, social media, and other new media companies and (ii) its semiconductor technologies and associated patent portfolios (“Semiconductor IP licensing”) to memory, sensor, radio frequency (“RF”) component, and foundry companies. The Company licenses its IP portfolios under three revenue models: (i) fixed-fee Media IP licensing, (ii) fixed-fee or minimum guarantee Semiconductor IP licensing, and (iii) per-unit or per-subscriber IP royalty licenses. Fixed-fee Media IP licensing The Company's long-term fixed-fee Media IP licensing agreements, which are related to the TiVo businesses following the Mergers, provide its customers with rights to future patented technologies over the term of the agreement that are highly interdependent or highly interrelated to the patented technologies provided at the inception of the agreement. The Company treats these rights as a single performance obligation with revenue recognized on a straight-line basis over the term of the fixed-fee license agreement. At times, the Company enters into license agreements in which a licensee is released from past patent infringement claims or is granted a license to ship an unlimited number of units or for an unlimited number of subscribers over a future period for a fixed fee. In these arrangements, the Company allocates the transaction price between the release for past patent infringement claims and the future license which requires significant management judgment. In determining the stand-alone selling price of the release for past patent infringement claims and the future license, the Company considers such factors as the number of units shipped in the past or the number of past subscribers and the relevant geographies of the shipped units or subscribers, the future number of subscribers or units, as well as the licensing rate the Company generally receives for per-subscriber or units shipped in the same geographies. As the release from past patent infringement claims is generally satisfied at execution of the agreement, the transaction price allocated to the release from past patent infringement claims is generally recognized in the period the agreement is executed and the amount of transaction price allocated to the future license is recognized ratably over the future license term. Fixed-fee or minimum guarantee Semiconductor IP licensing The Company enters into Semiconductor IP licenses that have fixed fee or minimum guarantee arrangements, whereby licensees pay a fixed fee for the right to incorporate the Company’s IP technologies in the licensee’s products over the license term. In arrangements with a minimum guarantee, the fixed fee component corresponds to a minimum number of units or dollars that the customer must produce or pay, with additional per-unit fees for any units or dollars exceeding the minimum. The Company generally recognizes the full fixed fee as revenue at the beginning of the license term when the customer has the right to use the IP and begins to benefit from the license, net of the effect of any significant financing components calculated using customer-specific, risk-adjusted lending rates, with the related interest income being recognized over time on an effective rate basis. For minimum guarantee agreements where the customer exceeds the minimum, the Company recognizes revenue relating to any additional per-unit fees in the periods it believes the customer will exceed the minimum and adjusts the revenue based on actual usage once that is reported by the customer. Per-unit or per-subscriber IP royalty licenses The Company recognizes revenue from per-unit or per-subscriber IP royalty licenses in the period in which the licensee's sales or production are estimated to have occurred, which results in an adjustment to revenue when actual sales or production are subsequently reported by the licensee, which is generally in the month or quarter following usage or shipment. Estimating customers’ monthly or quarterly royalties prior to receiving the royalty reports requires the Company to make significant assumptions and judgments related to forecasted trends and growth rates used to estimate quantities shipped or manufactured by customers, which could have a material impact on the amount of revenue it reports on a quarterly basis. Technology License The Company licenses The Company generally Certain e Technology Solutions Arrangements Technology Solutions customers are primarily multi-channel video service providers, CE manufacturers, and end consumers. Technology Solutions revenue is primarily derived from licensing the Company’s Pay-TV solutions, Personalized Content Discovery, enriched Metadata, and viewership data; selling TiVo-enabled devices like the Stream 4K; and advertising. For Technology Solutions, the Company provides on-going media or data delivery, hosting and access to its platform, and software updates. For these solutions, the Company generally receives fees on a per-subscriber per-month basis or as a fixed fee, and revenue is recognized during the month in which the solutions are provided to the customer. For most of the Technology Solutions offerings, substantially all functionality is obtained through the Company’s continuous hosting and/or updating of the data and content. In these instances, the Company typically has a single performance obligation related to these ongoing activities in the underlying arrangement. For those arrangements that include multiple performance obligations, the Company allocates the consideration as described above and recognizes revenue for each distinct performance obligation when control of the promised goods or services is transferred to the customer. The Company also generates revenue from non-recurring engineering (“NRE”) services, advertising, and hardware products, each of which was less than 5% of total revenue for all periods presented. Practical Expedients and Exemptions The Company applies a practical expedient to not perform an evaluation of whether a contract includes a significant financing component when the timing of revenue recognition differs from the timing of cash collection by one year or less. The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred as a component of selling, general and administrative expenses when the amortization period would have been one year or less. The Company applies a practical expedient when disclosing revenue expected to be recognized from unsatisfied performance obligations to exclude contracts with customers with an original duration of less than one year; amounts attributable to variable consideration arising from (i) a sales-based or usage-based royalty of an intellectual property license or (ii) when variable consideration is allocated entirely to a wholly unsatisfied performance obligation; or to a wholly unsatisfied promise to transfer a distinct good or service that forms part of a single performance obligation. Revenue Details The following information depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors by disaggregating revenue by product category/end market and geographic location (presented in “Note 16 - Segment and Geographic Information Revenue disaggregated by product category/end market was as follows (in thousands): Three Months Ended March 31, 2022 2021 IP Licensing revenue $ 138,531 $ 98,014 Pay-TV 64,155 63,743 Consumer Electronics 28,091 31,105 Connected Car 19,719 22,891 Media Platform 6,924 5,843 Total Product revenue 118,889 123,582 Total revenue $ 257,420 $ 221,596 Contract Balances Contracts Assets Contract assets primarily consist of unbilled contracts receivable that are expected to be received from customers in future periods, where the revenue recognized to date exceeds the amount billed. The amount of unbilled contracts receivable may not exceed their net realizable value and are classified as long-term assets if the payments are expected to be received more than one year from the reporting date. Contract assets also include the incremental costs of obtaining a contract with a customer, principally sales commissions when the renewal commission is not commensurate with the initial commission, and deferred engineering costs for significant software customization or modification and set-up services to the extent deemed recoverable. Contract assets were recorded in the Condensed Consolidated Balance Sheets as follows (in thousands ): March 31, 2022 December 31, 2021 Unbilled contracts receivable (1) $ 121,778 $ 77,677 Other current assets 1,157 1,150 Long-term unbilled contracts receivable (2) 43,112 4,107 Other long-term assets 2,216 2,310 Total contract assets $ 168,263 $ 85,244 (1) The unbilled contracts receivable increase relates primarily to a change in billing process in the three months ended March 31, 2022. This change has no impact on the Company’s cash flows. (2) The long-term unbilled contracts receivable increase relates primarily to the recognition of revenue from a multi-year contract with a customer in the three months ended March 31, 2022. Contract Liabilities Contract liabilities are mainly comprised of deferred revenue related to technology solutions arrangements, multi-period licensing, and other offerings for which the Company is paid in advance while the promised good or service is transferred to the customer at a future date or over time. Deferred revenue also includes amounts received related to professional services to be performed in the future. Deferred revenue arises when cash payments are received, including amounts which are refundable, in advance of performance obligations being completed. Allowance for Credit Losses The allowance for credit losses, which includes the allowance for accounts receivable and unbilled contracts receivable, represents the Company’s best estimate of lifetime expected credit losses inherent in those financial assets. The Company’s lifetime expected credit losses are determined using relevant information about past events (including historical experience), current conditions, and reasonable and supportable forecasts that affect collectability. The Company monitors its credit exposure through ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary. In addition, the Company performs routine credit management activities such as timely account reconciliations, dispute resolution, and payment confirmations. The Company may employ collection agencies and legal counsel to pursue recovery of defaulted receivables. The Company’s long-term unbilled contracts receivable is derived from fixed-fee or minimum-guarantee arrangements, primarily with large well-capitalized companies. It is generally considered to be of high credit quality due to past collection history and the nature of the customers. The following table presents the activity in the allowance for credit losses for the three months ended March 31, 2022 and 2021 (in thousands): Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Accounts Receivable Unbilled Contracts Receivable Accounts Receivable Unbilled Contracts Receivable Beginning balance $ 3,102 $ 729 $ 7,336 $ 2,231 Provision for (reversal of) credit losses (180 ) (111 ) 1,142 123 Recoveries (38 ) — (591 ) — Charged-off/other adjustments 11 (76 ) (3,849 ) (1 ) 530 Balance at end of period $ 2,895 $ 542 $ 4,038 $ 2,884 (1) The charge off of accounts receivable in the first quarter of 2021 was primarily related to a customer whose account had been substantially reserved for credit losses in 2020 due to deteriorating financial condition and delinquent payment history. Additional Disclosures The following table presents additional revenue and contract disclosures (in thousands): Three Months Ended March 31, 2022 2021 Revenue recognized in the period from: Amounts included in deferred revenue at the beginning of the period $ 10,241 $ 10,712 Performance obligations satisfied in previous periods (true ups, licensee reporting adjustments and settlements)* $ 153 $ 19,863 *True ups represent the differences between the Company’s quarterly estimates of per-unit royalty revenue and actual production/sales-based royalties reported by licensees in the following period. Licensee reporting adjustments represent corrections or revisions to previously reported per-unit royalties by licensees, generally resulting from the Company’s inquiries or compliance audits. Settlements represent resolutions of litigation during the period for past royalties owed pursuant to expired or terminated IP license agreements. Remaining revenue under contracts with performance obligations represents the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) under certain of the Company’s fixed fee arrangements and engineering services contracts. The Company's remaining revenue under contracts with performance obligations was as follows (in thousands) : As of March 31, 2022 December 31, 2021 Revenue from contracts with performance obligations expected to be satisfied in: 2022 (remaining 9 months) $ 130,163 $ 176,646 2023 155,635 153,746 2024 126,123 122,488 2025 112,594 110,703 2026 10,940 10,735 Thereafter 4,647 4,441 Total $ 540,102 $ 578,759

Composition of Certain Financia

Composition of Certain Financial Statement Captions	3 Months Ended
	Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Composition of Certain Financial Statement Captions	NOTE 4 – COMPOSITION OF CERTAIN FINANCIAL STATEMENT CAPTIONS Other current assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Prepaid income taxes $ 6,557 $ 6,103 Prepaid expenses 22,670 18,616 Inventory* 6,785 5,101 Other 6,725 6,639 $ 42,737 $ 36,459 *All inventory is finished goods. Property and equipment, net, consisted of the following (in thousands): March 31, 2022 December 31, 2021 Equipment, furniture and other $ 84,897 $ 81,076 Building and improvements 18,331 18,331 Land 5,300 5,300 Leasehold improvements 25,607 25,535 134,135 130,242 Less: accumulated depreciation and amortization (74,884 ) (69,268 ) $ 59,251 $ 60,974 Other long-term assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Long-term deferred tax assets $ 3,906 $ 3,758 Non-current income tax receivable 119,028 118,085 Other assets 27,707 26,122 $ 150,641 $ 147,965 Accrued liabilities consisted of the following (in thousands): March 31, 2022 December 31, 2021 Employee compensation and benefits $ 22,618 $ 42,075 Third-party royalties 4,470 4,428 Accrued expenses 29,885 38,089 Accrued severance 2,359 1,921 Current portion of operating lease liabilities 16,277 16,467 Other 23,931 7,725 $ 99,540 $ 110,705 Other long-term liabilities consisted of the following (in thousands): March 31, 2022 December 31, 2021 Long-term income tax payable $ 95,238 $ 91,614 Other 7,029 7,228 $ 102,267 $ 98,842 Accumulated other comprehensive loss consisted of the following (in thousands): March 31, 2022 December 31, 2021 Unrealized loss on available-for-sale debt securities, net of tax $ (243 ) $ (122 ) Foreign currency translation adjustment, net of tax (1,523 ) (630 ) $ (1,766 ) $ (752 )

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2022
Investments Debt And Equity Securities [Abstract]
Financial Instruments	NOTE 5 – FINANCIAL INSTRUMENTS The Company has investments in debt securities which include corporate bonds and notes, treasury and agency notes and bills, commercial paper, certificates of deposit, and in equity securities consisting of money market funds. The Company classifies its debt securities as available-for-sale (“AFS”), which are accounted for at fair value with credit related losses recognized as a provision for credit loss expense in its Condensed Consolidated Statements of Operations and all non-credit related unrealized gains and losses recognized in accumulated other comprehensive income or loss on the Condensed Consolidated Balance Sheets. Under ASU 2016-01 (Topic 321), equity securities are measured at fair value with unrealized gains and losses recognized in other income and expense, net, on the Condensed Consolidated Statements of Operations. The following is a summary of marketable securities at March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Estimated Fair Values Marketable securities Corporate bonds and notes $ 31,774 $ — $ (136 ) $ — $ 31,638 Commercial paper 64,867 1 (58 ) — 64,810 Total debt securities 96,641 1 (194 ) — 96,448 Money market funds 5,938 — — — 5,938 Total equity securities 5,938 — — — 5,938 Total marketable securities $ 102,579 $ 1 $ (194 ) $ — $ 102,386 Reported in: Cash and cash equivalents $ 49,666 Available-for-sale debt securities 52,720 Total marketable securities $ 102,386 December 31, 2021 Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit losses Estimated Fair Values Marketable securities Corporate bonds and notes $ 40,466 $ — $ (53 ) $ — $ 40,413 Commercial paper 49,609 — (18 ) — 49,591 Total debt securities 90,075 — (71 ) — 90,004 Money market funds 12,372 — — — 12,372 Total equity securities 12,372 — — — 12,372 Total marketable securities $ 102,447 $ — $ (71 ) $ — $ 102,376 Reported in: Cash and cash equivalents $ 41,842 Available-for-sale debt securities 60,534 Total marketable securities $ 102,376 At March 31, 2022 and December 31, 2021, the Company had $266.8 million and $261.7 million, respectively, in cash, cash equivalents and short-term investments. A significant portion of these amounts was held in marketable securities, as shown above. The remaining balance of $164.4 million and $159.3 million at March 31, 2022 and December 31, 2021, respectively, was cash held in operating accounts not included in the tables above. Debt Securities The gross realized gains and losses on sales of marketable debt securities were not material during the three months ended March 31, 2022 and 2021, respectively. Unrealized losses on AFS debt securities were $0.2 million and $0.1 million, net of tax, as of March 31, 2022 and December 31, 2021, respectively. The Company evaluated whether the decline in fair value has resulted from credit losses or other factors and concluded these amounts were related to temporary fluctuations in value of AFS securities and were due primarily to changes in interest rates and market conditions of the underlying securities. In addition, the contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. The Company does not intend to sell the debt securities and it is more-likely-than-not that it will not be required to sell the investments before recovery of their amortized cost bases. The Company did not recognize a provision for credit losses related to its AFS debt securities for the three months ended March 31, 2022 and 2021, respectively. The following table summarizes the fair value and gross unrealized losses related to individual AFS debt securities at March 31, 2022 and December 31, 2021, which have been in a continuous unrealized loss position, aggregated by investment category and length of time (in thousands): Less Than 12 Months 12 Months or More Total Fair Value March 31, 2022 Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Cash and Cash Equivalents AFS Debt Securities Corporate bonds and notes $ 18,212 $ (88 ) $ 11,926 $ (48 ) $ 30,138 $ (136 ) $ — $ 30,138 Commercial paper 56,564 (58 ) — — 56,564 (58 ) 35,482 21,082 Total $ 74,776 $ (146 ) $ 11,926 $ (48 ) $ 86,702 $ (194 ) $ 35,482 $ 51,220 Less Than 12 Months 12 Months or More Total Fair Value December 31, 2021 Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Cash and Cash Equivalents AFS Debt Securities Corporate bonds and notes $ 29,807 $ (45 ) $ 10,382 $ (8 ) $ 40,189 $ (53 ) $ — $ 40,189 Commercial paper 48,091 (18 ) — — 48,091 (18 ) 29,470 18,621 Total $ 77,898 $ (63 ) $ 10,382 $ (8 ) $ 88,280 $ (71 ) $ 29,470 $ 58,810 The estimated fair value of marketable debt securities by contractual maturity at March 31, 2022 is shown below (in thousands). Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without penalties. Estimated Fair Value Due in one year or less $ 48,599 Due in one to two years 4,121 Total $ 52,720 Non-marketable Equity Securities As of March 31, 2022 and December 31, 2021, other long-term assets included equity securities accounted for under the equity method with a carrying amount of $4.7 million and $4.8 million, respectively, and equity securities without a readily determinable fair value with a carrying amount of $0.1 million and $0.1 million, respectively. No impairments or adjustments to the carrying amount of the Company's equity securities without a readily determinable fair value were recognized in the three months ended March 31, 2022 and 2021, respectively.

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value	NOTE 6 – FAIR VALUE The Company follows the authoritative guidance for fair value measurement and the fair value option for financial assets and financial liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets. Level 2 Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. When applying fair value principles in the valuation of assets, the Company is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The Company calculates the fair value of its Level 1 and Level 2 instruments based on the exchange traded price of similar or identical instruments, where available, or based on other observable inputs. There were no significant transfers into or out of Level 1 or Level 2 that occurred between December 31, 2021 and March 31, 2022. The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of March 31, 2022 (in thousands): Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Marketable securities Money market funds - equity securities (1) $ 5,938 $ 5,938 $ — $ — Corporate bonds and notes - debt securities (2) 31,638 — 31,638 — Commercial paper - debt securities (3) 64,810 — 64,810 — Total Assets $ 102,386 $ 5,938 $ 96,448 $ — (1) Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet. (2) Reported as AFS debt securities in (3) Reported as cash and cash equivalents if purchased with an original maturity of three months or less at the date of purchase; otherwise reported as AFS debt securities in The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of December 31, 2021 (in thousands): Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Marketable securities Money market funds - equity securities (1) $ 12,372 $ 10,372 $ 2,000 $ — Corporate bonds and notes - debt securities (2) 40,413 — 40,413 — Commercial paper - debt securities (3) 49,591 — 49,591 — Total Assets $ 102,376 $ 10,372 $ 92,004 $ — (1) Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet. (2) Reported as AFS debt securities in the Condensed Consolidated Balance Sheet. (3) Reported as cash and cash equivalents if purchased with an original maturity of three months or less at the date of purchase; otherwise reported as AFS debt securities in Financial Instruments Not Recorded at Fair Value The Company’s long-term debt is carried at amortized cost and is measured at fair value on a quarterly basis for disclosure purposes. March 31, 2022 December 31, 2021 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value Refinanced Term B Loans (1) $ 756,485 $ 745,138 $ 765,487 $ 764,530 Total long-term debt, net $ 756,485 $ 745,138 $ 765,487 $ 764,530 (1) Carrying amounts of long-term debt are net of unamortized debt discount and issuance costs of $23.1 million and $24.3 million as of March 31, 2022 and December 31, 2021, respectively. See “Note 9 – Debt ” for additional information. If reported at fair value in the Condensed Consolidated Balance Sheets, the Company’s debt would be classified within Level 2 of the fair value hierarchy. The fair value of the debt was estimated based on the quoted market prices for the same or similar issues .

Business Combination

Business Combination	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Business Combination	NOTE 7 – BUSINESS COMBINATION On May 31, 2021, the Company completed its acquisition of certain assets and assumption of certain liabilities of MobiTV, Inc. (“MobiTV”, and the acquisition, the “MobiTV Acquisition”), a provider of application-based Pay-TV video delivery solutions. The acquisition expanded the Company’s IPTV Managed Service capabilities, which is expected to grow the addressable market for the Company’s IPTV products and further secure TiVo’s position as a leading provider of Pay-TV solutions. The net purchase price for the MobiTV Acquisition was $17.4 million in cash. Purchase Price Allocation The MobiTV Acquisition has been accounted for as a business combination, using the acquisition method. The following table presents the allocation of the purchase price to the identifiable assets acquired and liabilities assumed based on the fair values at the acquisition date, with any excess of the purchase price over the estimated fair value of the identifiable net assets acquired recorded to goodwill, all of which is expected to be deductible for tax purposes. The following table sets forth the final purchase price allocation with no measure period adjustments identified ($ in thousands): Estimated Useful Life (years) Final Fair Value Other current assets $ 390 Property and equipment 9,223 Operating lease right-of-use assets 1,186 Identifiable intangible assets: Patents 10 5,000 Technology 6 3,260 Total identifiable intangible assets 8,260 Goodwill 4,059 Other long-term assets 115 Accrued liabilities (5,288 ) Noncurrent operating lease liabilities (545 ) Total purchase price $ 17,400 The results of operations and cash flows relating to the business acquired pursuant to the MobiTV Acquisition have been included in the Company’s consolidated financial statements for periods subsequent to May 31, 2021, and the related assets and liabilities were recorded at their estimated fair values in the Company’s Consolidated Balance Sheet as of May 31, 2021. The operations acquired in the MobiTV Acquisition are included in the Company’s Product segment.

Goodwill and Identified Intangi

Goodwill and Identified Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Identified Intangible Assets	NOTE 8 – GOODWILL AND IDENTIFIED INTANGIBLE ASSETS Goodwill The changes to the carrying value of goodwill from January 1, 2022 through March 31, 2022 are reflected below (in thousands): December 31, 2021 $ 851,088 Goodwill adjustment related to Mergers in prior periods (1) (988 ) March 31, 2022 (2) $ 850,100 (1) Reflects the correction of an error in the purchase price allocation for the Mergers to reduce goodwill and revenue. The error was not material to the current period financial statements or any prior periods. (2) The Company's reporting units include the IP Licensing segment and the Product segment (defined further in “Note 16 - Segment and Geographic Information ”). Of the carrying value of goodwill, approximately $322.3 million was allocated to the IP Licensing segment and approximately $527.8 million was allocated to the Product segment as of each of March 31, 2022 and December 31, 2021. Goodwill at each reporting unit is evaluated for potential impairment annually, as of the beginning of the fourth quarter, and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable. Identified Intangible Assets Identified intangible assets consisted of the following (in thousands): Average March 31, 2022 December 31, 2021 Life (Years) Gross Assets Accumulated Amortization Net Gross Assets Accumulated Amortization Net Finite-lived intangible assets Acquired patents / core technology 3-10 $ 672,992 $ (238,788 ) $ 434,204 $ 672,872 $ (224,508 ) $ 448,364 Existing technology / content database 5-10 251,465 (211,712 ) 39,753 251,445 (206,934 ) 44,511 Customer contracts and related relationships 3-9 649,838 (379,519 ) 270,319 649,926 (360,543 ) 289,383 Trademarks/trade name 4-10 40,083 (27,079 ) 13,004 40,083 (25,825 ) 14,258 Non-competition agreements 1 2,231 (2,231 ) — 2,231 (2,231 ) — Total finite-lived intangible assets 1,616,609 (859,329 ) 757,280 1,616,557 (820,041 ) 796,516 Indefinite-lived intangible assets TiVo Tradename/trademarks N/A 21,400 — 21,400 21,400 — 21,400 Total intangible assets $ 1,638,009 $ (859,329 ) $ 778,680 $ 1,637,957 $ (820,041 ) $ 817,916 As of March 31, 2022, the estimated future amortization expense of total finite-lived intangible assets was as follows (in thousands): 2022 (remaining 9 months) $ 116,730 2023 145,084 2024 106,171 2025 81,716 2026 78,719 Thereafter 228,860 $ 757,280

Debt

Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Debt	NOTE 9 – DEBT The outstanding amounts of debt were as follows (in thousands): March 31, 2022 December 31, 2021 Refinanced Term B Loans $ 779,625 $ 789,750 Unamortized debt discount and issuance costs (23,140 ) (24,263 ) 756,485 765,487 Less: current portion, net of debt discount and issuance costs (36,152 ) (36,095 ) Total long-term debt, net of current portion $ 720,333 $ 729,392 Refinanced Term B Loans On June 8, 2021, the Company amended that certain Credit Agreement dated June 1, 2020 by and among the Company, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent (the “2020 Credit Agreement”). The 2020 Credit Agreement initially provided for a five-year The obligations under the 2020 Credit Agreement, inclusive of any changes by the Amendment, continue to be guaranteed by Xperi, TiVo and certain other of the Company’s wholly-owned material domestic subsidiaries (collectively, the “Guarantors”) and continue to be secured by a lien on substantially all of the assets of the Company and the Guarantors. The 2020 Credit Agreement, as amended, contains customary events of default, upon the occurrence of which, after any applicable cure period, the lenders will have the ability to accelerate all outstanding loans thereunder. The 2020 Credit Agreement, as amended, also contains customary representations and warranties and affirmative and negative covenants that, among other things and subject to certain exceptions, restrict the ability of the Company and its subsidiaries to create or incur certain liens, incur or guarantee additional indebtedness, merge or consolidate with other companies, transfer or sell assets and make restricted payments. The 2020 Credit Agreement, as amended, requires the Company to maintain a total net leverage ratio of no greater than 3.00x in order access an annual basket from which to make restricted payments (such as dividend payments and share repurchases). The Company was in compliance with all requirements as of March 31, 2022. The 2020 Credit Agreement, as amended, also requires the Company to make additional cash payments on an annual basis beginning in March 2023 based on certain leverage ratios and excess cash flow generated for the immediately preceding fiscal year. Certain lenders of the 2020 Term B Loan Facility participated in the Amendment and the changes in terms were not considered substantial. Accordingly, the Company accounted for the refinancing event for these lenders as a debt modification under ASC 470-50, “Debt — Modifications and Extinguishments.” Under its policy, the Company elected to continue to defer the unamortized debt discount and issuance costs for these continuing lenders related to the partial pay-down of the debt. Certain lenders of the 2020 Term B Loan Facility did not participate in the Amendment. Accordingly, the Company accounted for the refinancing event for these lenders as a debt extinguishment. As a result, the Company recorded an $8.0 million loss on debt extinguishment in the second quarter of 2021, related to the write-off of unamortized debt discount and issuance costs for the portions of the 2020 Term B Loan Facility considered to be extinguished. In connection with its entry into the Amendment, the Company incurred $6.8 million in debt financing costs, of which $4.2 million were capitalized in accordance with ASC 835-30 “Debt Issuance Costs” and, together with a portion of the unamortized debt discount and issuance costs from the 2020 Term B Loan Facility, are being amortized into interest expense over the term of the Amendment. Under ASC 470-50, the remaining $2.6 million, primarily related to third-party fees, were recorded as selling, general and administrative expense in the second quarter of 2021. Interest Expense and Expected Principal Payments At March 31, 2022, $779.6 million in total debt was outstanding. There were also $23.1 million of unamortized debt discount and issuance costs recorded as a reduction from the carrying amount of the debt. Interest rate on the Refinanced Term B Loans, including the amortization of debt discount and issuance costs was 4.2% and interest was payable monthly. Interest expense was $8.4 million and $11.3 million for the three months ended March 31, 2022 and 2021, respectively. Amortized debt discount and issuance costs, which were included in interest expense, amounted to $1.1 million and $2.3 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, future minimum principal payments for long-term debt are summarized as follows (in thousands): 2022 (remaining 9 months) $ 30,375 2023 40,500 2024 40,500 2025 40,500 2026 40,500 Thereafter 587,250 Total $ 779,625

Net Income Per Share

Net Income Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Income Per Share	NOTE 10 – NET INCOME PER SHARE The following table sets forth the computation of basic and diluted shares (in thousands): Three Months Ended March 31, 2022 March 31,2021 Denominator: Weighted average shares of common stock outstanding 103,679 104,940 Total common shares-basic 103,679 104,940 Effect of dilutive securities: Options 3 32 Restricted stock awards and units 1,650 2,804 Total common shares-diluted 105,332 107,776 Basic net income per share is computed using the weighted average number of shares of common stock outstanding during the period, excluding any unvested restricted stock awards that are subject to repurchase. Diluted net income per share is computed using the treasury stock method to calculate the weighted average number of shares of common stock and, if dilutive, potential common shares outstanding during the period. Potentially dilutive common shares include unvested restricted stock awards and units and incremental common shares issuable upon the exercise of stock options, less shares repurchased from assumed proceeds. The assumed proceeds calculation includes actual proceeds to be received from the employee upon exercise and the average unrecognized stock compensation cost during the period. In the calculation of net income per share for the three months ended March 31, 2022 and 2021, 3.6 million and 1.1 million shares, respectively, subject to stock options and restricted stock awards and units were excluded from the computation of diluted net income per share as they were anti-dilutive.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stockholders' Equity	NOTE 11 – STOCKHOLDERS’ EQUITY Equity Incentive Plans The 2020 EIP In connection with the Mergers and immediately prior to June 1, 2020, the Company adopted the Xperi Holding Corporation 2020 Equity Incentive Plan (the “2020 EIP”). Under the 2020 EIP, the Company may grant equity-based awards to employees, non-employee directors, and consultants for services rendered to the Company (or any parent or subsidiary) in the form of stock options, stock awards, restricted stock awards, restricted stock units, stock appreciation rights, dividend equivalents and performance awards (or any combination thereof). A total of 8,000,000 shares have been reserved for issuance under the 2020 EIP provided that each share issued pursuant to “full value” awards (i.e., stock awards, restricted stock awards, restricted stock units, performance awards and dividend equivalents) are counted against shares available for issuance under the 2020 EIP on a 1.5 to 1 ratio. The 2020 EIP provides for option grants designed as either incentive stock options or nonstatutory options. Options generally are granted with an exercise price not less than the value of the common stock on the grant date and have a term of ten years from the date of grant and vest over a four-year Assumed Plans On June 1, 2020, the Company assumed all then-outstanding stock options, awards, and shares available and reserved for issuance under all legacy Equity Incentive Plans of TiVo (collectively, the “Assumed Plans”). Stock options assumed from the Assumed Plans generally have vesting periods of four years and a contractual term of seven years. Awards of restricted stock and restricted stock units assumed from the Assumed Plans are generally subject to a four year vesting period. The number of shares subject to stock options and restricted stock unit awards outstanding under these plans are included in the tables below. Shares reserved under the Assumed Plans will be available for future grants. As of March 31, 2022, there were 1.8 million shares reserved for future grants under both the 2020 EIP and the Assumed Plans. A summary of the stock option activity is presented below (in thousands, except per share amounts): Options Outstanding Number of Shares Subject to Options Weighted Average Exercise Price Per Share Balance at December 31, 2021 447 $ 25.22 Options granted — $ — Options exercised (1 ) $ 17.60 Options canceled / forfeited / expired (22 ) $ 54.69 Balance at March 31, 2022 424 $ 23.64 Restricted Stock Awards and Units Information with respect to outstanding restricted stock awards and units (including both time-based vesting and performance-based vesting) as of March 31, 2022 is as follows (in thousands, except per share amounts): Restricted Stock and Restricted Stock Units Number of Shares Subject to Time- based Vesting Number of Shares Subject to Performance- based Vesting Total Number of Shares Weighted Average Grant Date Fair Value Per Share Balance at December 31, 2021 6,815 1,525 8,340 $ 19.61 Awards and units granted 1,918 — 1,918 $ 17.38 Awards and units vested / earned (1,274 ) (335 ) (1,609 ) $ 20.87 Awards and units canceled / forfeited (339 ) (174 ) (513 ) $ 19.73 Balance at March 31, 2022 7,120 1,016 8,136 $ 18.83 Performance Awards and Units Performance awards and units may be granted to employees or consultants based upon, among other things, the contributions, responsibilities and other compensation of the particular employee or consultant. The value and the vesting of such performance awards and units are generally linked to one or more performance goals or certain market conditions determined by the Company, in each case on a specified date or dates or over any period or periods determined by the Company, and may range from zero to 200 percent of the grant. For performance awards subject to a market vesting condition (“market-based PSUs”), the fair value per award is fixed at the grant date and the amount of compensation expense is not adjusted during the performance period regardless of changes in the level of achievement of the market condition. Employee Stock Purchase Plans Prior to the Mergers, the Company had implemented the Xperi Corporation 2003 Employee Stock Purchase Plan and the International Employee Stock Purchase Plan, both of which were terminated immediately prior to the effective time of the Mergers. In connection with the Mergers and immediately prior to June 1, 2020, the Company adopted the Xperi Holding Corporation 2020 Employee Stock Purchase Plan (the “2020 ESPP”). The 2020 ESPP is implemented through consecutive overlapping 24-month offering periods, each of which is comprised of four six-month purchase periods. The first offering period commenced on September 1, 2020 and will end on August 31, 2022. Each subsequent offering period under the 2020 ESPP will be twenty-four (24) months long and will commence on each September 1 and March 1 during the term of the plan. Participants may contribute up to 100% of their base earnings and commissions through payroll deductions, and the accumulated deductions will be applied to the purchase of shares on each semi-annual purchase date. The purchase price per share will equal 85% of the fair market value per share on the start date of the offering period or, if lower, 85% of the fair market value per share on the semi-annual purchase date. An eligible employee’s right to buy the Company’s common stock under the 2020 ESPP may not accrue at a rate in excess of $25,000 of the fair market value of such shares per calendar year for each calendar year of an offering period. If the fair market value per share of the Company’s common stock on any purchase date during an offering period is less than the fair market value per share on the start date of the 24-month offering period, then that offering period will automatically terminate and a new 24-month offering period will begin on the next business day. All participants in the terminated offering will be transferred to the new offering period. As of March 31, 2022, there were 0.1 million shares reserved for grant under the Company’s 2020 ESPP. Stock Repurchase Programs Following the termination of Xperi’s prior stock repurchase program after the closing of the Mergers, on June 12, 2020 the Board of Directors (the “Board”) of the Company authorized a new stock repurchase program providing for the repurchase of up to $150.0 million of the Company's Common Stock dependent on market conditions, share prices and other factors. On April 22, 2021, the Board authorized an additional $100.0 million of purchases under the existing stock repurchase plan. As of March 31, 2022, the Company has repurchased a total of approximately 10.0 million shares of common stock, since inception of the plan, at an average price of $17.24 per share for a total cost of $172.2 million. As of December 31, 2021, the Company had repurchased a total of approximately 9.0 million shares of common stock, since inception of the plan, at an average price of $17.29 per share for a total cost of $155.0 million. The shares repurchased are recorded as treasury stock and are accounted for under the cost method. No expiration date has been specified for this plan. As of March 31, 2022, the total remaining amount available for repurchase under this plan was $77.8 million. The Company plans to continue to execute authorized repurchases from time to time under the plan. The Company issues restricted stock units as part of the equity incentive plans described above. For the majority of restricted awards, shares are withheld to satisfy required withholding taxes at the vesting date. Shares withheld to satisfy required withholding taxes in connection with the vesting of restricted awards are treated as common stock repurchases in the condensed consolidated financial statements because they reduce the number of shares that would have been issued on vesting. However, these withheld shares are not included in common stock repurchases under the Company's authorized share repurchase plan. During the three months ended March 31, 2022 and 2021, the Company withheld 0.7 million and 0.3 million shares of common stock to satisfy $11.1 million and $7.4 million of required withholding taxes, respectively.

Stock-Based Compensation Expens

Stock-Based Compensation Expense	3 Months Ended
	Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation Expense	NOTE 12 – STOCK-BASED COMPENSATION EXPENSE The effect of recording stock-based compensation (“SBC”) expense for the three months ended March 31, 2022 and 2021 is as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Cost of revenue, excluding depreciation and amortization of intangible assets $ 628 $ 323 Research, development and other related costs 5,475 4,347 Selling, general and administrative 10,701 8,549 Total stock-based compensation expense 16,804 13,219 Tax effect on stock-based compensation expense (172 ) (154 ) Net effect on net income (loss) $ 16,632 $ 13,065 SBC expense categorized by various equity components for the three months ended March 31, 2022 and 2021 is summarized in the table below (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Restricted stock awards and units $ 15,220 $ 11,929 Employee stock purchase plan 1,584 1,271 Employee stock options — 19 Total stock-based compensation expense $ 16,804 $ 13,219 In connection with termination of employment with a former executive on March 1, 2022, the Company entered into a Separation Agreement and Release with the executive, dated February 18, 2022 (the “Separation Agreement”). Pursuant to the Separation Agreement, the Company approved, among other severance benefits, accelerated vesting of 372,244 of outstanding performance and time-based restricted stock units. As a result of this modification, the Company recorded incremental SBC of approximately $2.2 million for the three months ended March 31, 2022. There were no options granted in the three months ended March 31, 2022 and 2021. The following assumptions were used to value the restricted stock units subject to market conditions granted during the period: March 2022* March 2021 Expected life (years) — 3.0 Risk-free interest rate — 0.3 % Dividend yield — 1.0 % Expected volatility — 47.9 % *There were no market-based restricted stock units granted in the three months ended March 31, 2022. ESPP grants occur in March and September. The following assumptions were used to value the ESPP shares for these grants: March 2022 September 2021 March 2021 Expected life (years) 2.0 2.0 2.0 Risk-free interest rate 1.3 % 0.2 % 0.1 % Dividend yield 1.1 % 0.9 % 1.2 % Expected volatility 48.5 % 52.0 % 52.0 %

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 13 – INCOME TAXES For the three months ended March 31, 2022, the Company recorded an income tax expense of $21.5 million For the three months ended March 31, 2021, the Company recorded an income tax benefit of $4.0 million on pretax income of $0.5 million, which resulted in an effective tax rate of (786.4)%. The income tax benefit for the three months ended March 31, 2021 was primarily related to foreign withholding taxes, BEAT and unrealized foreign exchange loss from the prior year South Korea refund claims. The Company’s negative effective tax rate is based on the projected 2021 GAAP U.S. pretax loss and is significantly less than the 21% U.S. federal tax rate. The Company’s effective tax rate is the result of the most significant components of income tax expense, primarily driven by foreign withholding and BEAT. The computed negative effective tax rate is applied to the year-to-date U.S. profit resulting in an income tax benefit for the quarter ended March 31, 2021. As of March 31, 2022, gross unrecognized tax benefits increased $3.6 million to $244.0 million compared to $240.4 million as of December 31, 2021. This was included in long-term deferred tax and other long-term liabilities on the Condensed Consolidated Balance Sheets. Of this amount, $95.2 million would affect the effective tax rate if recognized. As of March 31, 2021, unrecognized tax benefits of $228.7 million were included in long-term deferred tax and other long-term liabilities on the Condensed Consolidated Balance Sheets. Of this amount, $96.0 million would affect the effective tax rate if recognized. The Company is unable to reasonably estimate the timing of the long-term payments or the amount by which the liability will increase or decrease. It is the Company's policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company recognized interest and penalties related to unrecognized tax benefits of $0.2 million and $0.6 million for the three months ended March 31, 2022 and 2021, respectively. Accrued interest and penalties were $3.1 million and $2.8 million as of March 31, 2022 and December 31, 2021, respectively. As of March 31, 2022, the Company’s 2017 through 2021 tax years are generally open and subject to potential examination in one or more jurisdictions. Earlier tax years for the Company and its subsidiaries are also open in certain jurisdictions which are currently subject to examination. In addition, in the U.S., any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company has submitted a withholding tax refund claim with the South Korean authorities and the final outcome is not anticipated to be settled within the next twelve months.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	NOTE 14 – LEASES The Company leases office and research facilities, data centers and office equipment under operating leases which expire through 2029. The Company’s leases have remaining lease terms of one year to eight years, some of which may include options to extend the leases for five years or longer, and some of which may include options to terminate the leases within the next 6 years or less. Leases with an initial term of 12 months or less are not recorded on the balance sheets; expense for these leases is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the lease liability and right-of-use assets calculation. As a practical expedient, the Company elected, for all office and facility leases, not to separate nonlease components (e.g., common-area maintenance costs) from lease components (e.g., fixed payments including rent) and instead to account for each separate lease component and its associated non-lease components as a single lease component. As most of the leases do not provide an implicit rate, the Company generally, for purposes of discounting lease payments, uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The Company subleases certain real estate to third parties. The sublease portfolio consists of operating leases for previously exited office space. Certain subleases include variable payments for operating costs. The subleases are generally co-terminus with the head lease, or shorter. Subleases do not include any residual value guarantees or restrictions or covenants imposed by the leases. Income from subleases is recognized as a reduction to selling, general and administrative expenses. The components of operating lease costs were as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Fixed lease cost (1) $ 5,526 $ 5,466 Variable lease cost 1,274 1,365 Less: sublease income (2,106 ) (2,188 ) Total operating lease cost $ 4,694 $ 4,643 (1) Includes short-term leases, which were immaterial. Other information related to leases was as follows (in thousands, except lease term and discount rate): Three Months Ended, March 31, 2022 March 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 5,585 $ 5,555 ROU assets obtained in exchange for new lease liabilities: Operating leases $ 1,908 $ — March 31, 2022 December 31, 2021 Weighted-average remaining lease term (years): Operating leases 4.2 4.4 Weighted-average discount rate: Operating leases 5.0 % 5.0 % Future minimum lease payments and related lease liabilities as of March 31, 2022 were as follows (in thousands): Operating Lease Payments (1) Sublease Income Net Operating Lease Payments 2022 (remaining 9 months) $ 14,479 $ (5,470 ) $ 9,009 2023 19,179 (7,618 ) 11,561 2024 17,253 (7,610 ) 9,643 2025 15,374 (7,386 ) 7,988 2026 6,586 (935 ) 5,651 Thereafter 3,244 — 3,244 Total lease payments 76,115 (29,019 ) 47,096 Less: imputed interest (7,908 ) — (7,908 ) Present value of lease liabilities: $ 68,207 $ (29,019 ) $ 39,188 Less: current obligations under leases (accrued liabilities) 16,277 Noncurrent operating lease liabilities $ 51,930 (1) Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 15 – COMMITMENTS AND CONTINGENCIES Purchase and Other Contractual Obligations In the ordinary course of business, the Company enters into contractual agreements with third parties that include non-cancelable payment obligations, for which it is liable in future periods. These arrangements primarily include unconditional purchase obligations to service providers. As of March 31, 2022, the Company’s total future unconditional purchase obligations were approximately $116.6 million. Inventory Purchase Commitment The Company uses contract manufacturers to provide manufacturing services for its products. During the normal course of business, in order to manage manufacturing lead times and help ensure adequate supply, the Company enters into agreements with its contract manufacturers that either allow them to procure inventory based on criteria as defined by the Company or that establish the parameters defining the Company’s requirements. A significant portion of the Company’s purchase commitments arising from these agreements consist of firm, non-cancelable and unconditional purchase commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule or adjust the Company’s requirements based on its business needs prior to firm orders being placed. As of March 31, 2022, the Company had total purchase commitments for inventory of $9.8 million, of which $2.9 million was accrued in the Condensed Consolidated Balance Sheet. Indemnifications In the normal course of business, the Company provides indemnifications of varying scopes and amounts to certain of its licensees, customers, and business partners against claims made by third parties arising from the use of the Company's products, intellectual property, services or technologies. The Company cannot reasonably estimate the possible range of losses that may be incurred pursuant to its indemnification obligations, if any. Variables affecting any such assessment include, but are not limited to: the nature of the claim asserted; the relative merits of the claim; the financial ability of the party suing the indemnified party to engage in protracted litigation; the number of parties seeking indemnification; the nature and amount of damages claimed by the party suing the indemnified party; and the willingness of such party to engage in settlement negotiations. To date, no such claims have been filed against the Company and no liability has been recorded in the Company’s financial statements. As permitted under Delaware law, the Company has agreements whereby it indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company believes, given the absence of any such payments in the Company’s history, and the estimated low probability of such payments in the future, that the estimated fair value of these indemnification agreements is immaterial. In addition, the Company has directors’ and officers’ liability insurance coverage that is intended to reduce its financial exposure and may enable the Company to recover any payments under the indemnification agreements, should they occur . Contingencies At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of losses is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company is currently unable to predict the final outcome of lawsuits to which it is a party and therefore cannot determine the likelihood of loss nor estimate a range of possible losses. An adverse decision in any of these proceedings could significantly harm the Company’s business and consolidated financial position, results of operations or cash flows. The Company and its subsidiaries are involved in litigation matters and claims in the normal course of business. In the past, the Company and its subsidiaries have litigated to enforce their respective patents and other intellectual property rights, to enforce the terms of license agreements, to protect trade secrets, to determine the validity and scope of the proprietary rights of others and to defend itself or its customers against claims of infringement or invalidity. The Company expects it or its subsidiaries will be involved in similar legal proceedings in the future, including proceedings regarding infringement of its patents, and proceedings to ensure proper and full payment of royalties by licensees under the terms of its license agreements. The existing and any future legal actions may harm the Company’s business. For example, legal actions could cause an existing licensee or strategic partner to cease making royalty or other payments to the Company, or to challenge the validity and enforceability of patents owned by the Company’s subsidiaries or the scope of license agreements with the Company’s subsidiaries, or could significantly damage the Company’s relationship with such licensee or strategic partner and, as a result, prevent the adoption of the Company’s other technologies by such licensee or strategic partner. Litigation could also severely disrupt or shut down the business operations of licensees or strategic partners of the Company’s subsidiaries, which in turn would significantly harm ongoing relations with them and cause the Company to lose royalty revenue. The costs associated with legal proceedings are typically high, relatively unpredictable, and not completely within the Company’s control. These costs may be materially higher than expected, which could adversely affect the Company’s operating results and lead to volatility in the price of its common stock. Whether or not determined in the Company’s favor or ultimately settled, litigation diverts managerial, technical, legal, and financial resources from the Company’s business operations. Furthermore, an adverse decision in any of these legal actions could result in a loss of the Company’s proprietary rights, subject the Company to significant liabilities, require the Company to seek licenses from others, limit the value of the Company’s licensed technology or otherwise negatively impact the Company’s stock price or its business and consolidated financial results.

Segment and Geographic Informat

Segment and Geographic Information	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment and Geographic Information	NOTE 16 – SEGMENT AND GEOGRAPHIC INFORMATION The Company reports its financial results within two reportable segments: (1) Intellectual Property (“IP”) Licensing and (2) Product. There are certain corporate overhead costs that are not allocated to these reportable segments because these operating amounts are not considered in evaluating the operating performance of the Company’s business segments. Reportable segments are identified based on the Company's organizational structure and information reviewed by the Company’s chief operating decision maker (“CODM”) to evaluate performance and allocate resources. The Company’s Chief Executive Officer is also the CODM as defined by the authoritative guidance on segment reporting. The IP Licensing segment consists primarily of licensing the Company’s innovations to leading companies in the broader entertainment and semiconductor industries, and those developing new technologies that will help drive the industries forward. Licensing arrangements include access to one or more of the Company’s foundational patent portfolios and may also include access to some of its industry-leading technologies and proven know-how. In its Product segment, the Company derives the majority of its revenue from licensing its technology to customers primarily through Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology. The Company does not identify or allocate assets by reportable segment, nor does the CODM evaluate reportable segments using discrete asset information. Reportable segments do not record inter-segment revenue and accordingly there are none to report. The Company does not allocate other income and expense to reportable segments. Although the CODM uses operating income to evaluate reportable segments, operating costs included in one segment may benefit other segments. The following table sets forth the Company’s segment revenue, operating expenses and operating income for the three months ended March 31, 2022 and 2021 (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Revenue: IP Licensing segment $ 138,531 $ 98,014 Product segment 118,889 123,582 Total revenue 257,420 221,596 Operating expenses: IP Licensing segment 35,292 33,567 Product segment 97,511 108,563 Unallocated operating expenses (1) 71,648 69,067 Total operating expenses 204,451 211,197 Operating income: IP Licensing segment 103,239 64,447 Product segment 21,378 15,019 Unallocated operating expenses (1) (71,648 ) (69,067 ) Total operating income $ 52,969 $ 10,399 (1) Unallocated operating expenses consist primarily of selling, marketing, general and administrative expenses, such as administration, human resources, finance, information technology, corporate development and procurement. These expenses are not allocated because these amounts are not considered in evaluating the operating performance of the Company’s business segments. A significant portion of the Company’s revenue is derived from licensees headquartered outside of the U.S., and it is expected that this revenue will continue to account for a significant portion of total revenue in future periods. The table below lists the geographic revenue for the periods indicated (in thousands): Three Months Ended March 31, 2022 March 31, 2021 U.S. $ 182,846 71 % $ 131,498 59 % Japan 18,884 7 26,444 12 South Korea 7,056 3 18,513 9 Europe and Middle East 13,020 5 16,422 7 Other 35,614 14 28,719 13 $ 257,420 100 % $ 221,596 100 % For the three months ended March 31, 2022 and 2021, there were one customer and no customers, respectively, that each accounted for 10% or more of total revenue. As of both March 31, 2022 and December 31, 2021, there was one customer that individually accounted for 10% or more of total accounts receivable.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 17 - SUBSEQUENT EVENTS On April 29, 2022, the Board declared a cash dividend of $0.05 per share of common stock, payable on June 21, 2022 to the stockholders of record at the close of business on May 31, 2022. At the 2022 annual stockholders meeting on April 29, 2022, shareholders approved (i) an amendment to the 2020 EIP adding an additional 8.8 million shares to the share reserve and (ii) an amendment to the 2020 ESPP adding an additional 6.0 million shares to the share reserve.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Accounting	The accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles (“GAAP”) in the United States (“U.S.”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. The amounts as of December 31, 2021 have been derived from the Company’s annual audited financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021, filed on February 24, 2022 (the “Form 10-K”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary (consisting of normal recurring adjustments) to state fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These financial statements should be read in conjunction with the annual audited financial statements and notes thereto as of and for the year ended December 31, 2021, included in the Form 10-K.
Reclassification	Reclassification Certain reclassifications have been made to prior period balances in order to conform to the current period’s presentation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, challenging, and subjective judgment include the estimation of licensees’ quarterly royalties prior to receiving the royalty reports, the determination of stand-alone selling price and the transaction price in an arrangement with multiple performance obligations, the estimation of variable consideration, the assessment of the recoverability of goodwill, the assessment of useful lives and recoverability of other intangible assets and long-lived assets, recognition and measurement of current and deferred income tax assets and liabilities, the assessment of unrecognized tax benefits, and purchase accounting resulting from business combinations, among others. Actual results experienced by the Company may differ from management’s estimates. The COVID-19 pandemic has resulted in a global slowdown of economic activity which has reduced demand for a broad variety of goods and services, while disrupting sales channels, marketing activities and supply chains. The Company’s business operations have been negatively impacted by the COVID-19 pandemic and related events, and the Company expects this disruption may continue to have a negative impact on its revenue and results of operations, especially in light of the spread of the highly transmissible BA.2 Omicron subvariant and potential new variants that may arise in the future. The full extent of the future impact of the COVID-19 pandemic on the Company’s operational and financial performance is currently uncertain and will depend on many factors outside the Company’s control, including, without limitation, the timing, extent, trajectory and duration of the pandemic; the availability, distribution and effectiveness of vaccines; the spread of new variants of COVID-19; the continued or renewed imposition of protective public safety measures; the continuing disruption of the global supply chain affecting the Company’s industry; and the impact of the pandemic on the global economy and demand for consumer products. The impact of the COVID-19 pandemic and related events, including actions taken by various government authorities in response, have increased market volatility and make the estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes more difficult. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require it to update its estimates, judgments or revise the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known.
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Recent Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting
Revenue Recognition	Revenue Recognition General Revenue is recognized when control of the promised goods or services is transferred to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services, which may include various combinations of goods and services which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of sales taxes collected from customers which are subsequently remitted to governmental authorities. In situations where foreign withholding taxes are withheld by the Company’s licensee, revenue is recognized gross of withholding taxes that are remitted directly by the licensee to a local tax authority. Some of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are separately accounted for if they are distinct. In an arrangement with multiple performance obligations, the transaction price is allocated among the separate performance obligations on a relative stand-alone selling price basis. The determination of stand-alone selling price considers market conditions, the size and scope of the contract, customer and geographic information, and other factors. When observable prices are not available, stand-alone selling price for separate performance obligations is based on the cost-plus-margin approach, considering overall pricing objectives. The allocation of transaction price among performance obligations in a contract may impact the amount and timing of revenue recognized in the Condensed Consolidated Statements of Operations during a given period. When a contract with a customer includes a variable transaction price, an estimate of the consideration which the Company expects to be entitled to for transferring the promised goods or services is made at contract inception. The amount of variable consideration is estimated at contract inception by considering all available information (historical, current and forecast) at the time and updated as additional information becomes available. The estimate of variable consideration is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Subsequent changes in the transaction price resulting from changes in the estimate of variable consideration are allocated to the performance obligations in the contract on the same basis as at contract inception. When variable consideration is in the form of a sales-based or usage-based royalty in exchange for a license of IP, or when a license of IP is the predominant item to which the variable consideration relates, revenue is recognized at the later of when the subsequent sale or usage occurs or the performance obligation to which some or all of the sales-based or usage-based royalty has been allocated has been satisfied or partially satisfied. Description of Revenue-Generating Activities The Company operates in two business segments. In its IP Licensing segment, the Company licenses its innovations to leading companies in the broader entertainment and semiconductor industries, and those developing new technologies that will help drive the industries forward. Licensing arrangements include access to one or more of the Company’s foundational patent portfolios and may also include access to some of its industry-leading technologies and proven know-how. In its Product segment, the Company derives the majority of its revenue from licensing its technology to customers primarily through Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology. IP License Arrangements In its IP Licensing segment, the Company licenses (i) its media patent portfolios (“Media IP licensing”) to multichannel video programming distributors, over-the-top video service providers, consumer electronics manufacturers, social media, and other new media companies and (ii) its semiconductor technologies and associated patent portfolios (“Semiconductor IP licensing”) to memory, sensor, radio frequency (“RF”) component, and foundry companies. The Company licenses its IP portfolios under three revenue models: (i) fixed-fee Media IP licensing, (ii) fixed-fee or minimum guarantee Semiconductor IP licensing, and (iii) per-unit or per-subscriber IP royalty licenses. Fixed-fee Media IP licensing The Company's long-term fixed-fee Media IP licensing agreements, which are related to the TiVo businesses following the Mergers, provide its customers with rights to future patented technologies over the term of the agreement that are highly interdependent or highly interrelated to the patented technologies provided at the inception of the agreement. The Company treats these rights as a single performance obligation with revenue recognized on a straight-line basis over the term of the fixed-fee license agreement. At times, the Company enters into license agreements in which a licensee is released from past patent infringement claims or is granted a license to ship an unlimited number of units or for an unlimited number of subscribers over a future period for a fixed fee. In these arrangements, the Company allocates the transaction price between the release for past patent infringement claims and the future license which requires significant management judgment. In determining the stand-alone selling price of the release for past patent infringement claims and the future license, the Company considers such factors as the number of units shipped in the past or the number of past subscribers and the relevant geographies of the shipped units or subscribers, the future number of subscribers or units, as well as the licensing rate the Company generally receives for per-subscriber or units shipped in the same geographies. As the release from past patent infringement claims is generally satisfied at execution of the agreement, the transaction price allocated to the release from past patent infringement claims is generally recognized in the period the agreement is executed and the amount of transaction price allocated to the future license is recognized ratably over the future license term. Fixed-fee or minimum guarantee Semiconductor IP licensing The Company enters into Semiconductor IP licenses that have fixed fee or minimum guarantee arrangements, whereby licensees pay a fixed fee for the right to incorporate the Company’s IP technologies in the licensee’s products over the license term. In arrangements with a minimum guarantee, the fixed fee component corresponds to a minimum number of units or dollars that the customer must produce or pay, with additional per-unit fees for any units or dollars exceeding the minimum. The Company generally recognizes the full fixed fee as revenue at the beginning of the license term when the customer has the right to use the IP and begins to benefit from the license, net of the effect of any significant financing components calculated using customer-specific, risk-adjusted lending rates, with the related interest income being recognized over time on an effective rate basis. For minimum guarantee agreements where the customer exceeds the minimum, the Company recognizes revenue relating to any additional per-unit fees in the periods it believes the customer will exceed the minimum and adjusts the revenue based on actual usage once that is reported by the customer. Per-unit or per-subscriber IP royalty licenses The Company recognizes revenue from per-unit or per-subscriber IP royalty licenses in the period in which the licensee's sales or production are estimated to have occurred, which results in an adjustment to revenue when actual sales or production are subsequently reported by the licensee, which is generally in the month or quarter following usage or shipment. Estimating customers’ monthly or quarterly royalties prior to receiving the royalty reports requires the Company to make significant assumptions and judgments related to forecasted trends and growth rates used to estimate quantities shipped or manufactured by customers, which could have a material impact on the amount of revenue it reports on a quarterly basis. Technology License The Company licenses The Company generally Certain e Technology Solutions Arrangements Technology Solutions customers are primarily multi-channel video service providers, CE manufacturers, and end consumers. Technology Solutions revenue is primarily derived from licensing the Company’s Pay-TV solutions, Personalized Content Discovery, enriched Metadata, and viewership data; selling TiVo-enabled devices like the Stream 4K; and advertising. For Technology Solutions, the Company provides on-going media or data delivery, hosting and access to its platform, and software updates. For these solutions, the Company generally receives fees on a per-subscriber per-month basis or as a fixed fee, and revenue is recognized during the month in which the solutions are provided to the customer. For most of the Technology Solutions offerings, substantially all functionality is obtained through the Company’s continuous hosting and/or updating of the data and content. In these instances, the Company typically has a single performance obligation related to these ongoing activities in the underlying arrangement. For those arrangements that include multiple performance obligations, the Company allocates the consideration as described above and recognizes revenue for each distinct performance obligation when control of the promised goods or services is transferred to the customer. The Company also generates revenue from non-recurring engineering (“NRE”) services, advertising, and hardware products, each of which was less than 5% of total revenue for all periods presented. Practical Expedients and Exemptions The Company applies a practical expedient to not perform an evaluation of whether a contract includes a significant financing component when the timing of revenue recognition differs from the timing of cash collection by one year or less. The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred as a component of selling, general and administrative expenses when the amortization period would have been one year or less. The Company applies a practical expedient when disclosing revenue expected to be recognized from unsatisfied performance obligations to exclude contracts with customers with an original duration of less than one year; amounts attributable to variable consideration arising from (i) a sales-based or usage-based royalty of an intellectual property license or (ii) when variable consideration is allocated entirely to a wholly unsatisfied performance obligation; or to a wholly unsatisfied promise to transfer a distinct good or service that forms part of a single performance obligation.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue From Contract With Customer [Abstract]
Schedule of Revenue Disaggregated by Product Category/End Market	Revenue disaggregated by product category/end market was as follows (in thousands): Three Months Ended March 31, 2022 2021 IP Licensing revenue $ 138,531 $ 98,014 Pay-TV 64,155 63,743 Consumer Electronics 28,091 31,105 Connected Car 19,719 22,891 Media Platform 6,924 5,843 Total Product revenue 118,889 123,582 Total revenue $ 257,420 $ 221,596
Schedule of Contract Assets	Contract assets were recorded in the Condensed Consolidated Balance Sheets as follows (in thousands ): March 31, 2022 December 31, 2021 Unbilled contracts receivable (1) $ 121,778 $ 77,677 Other current assets 1,157 1,150 Long-term unbilled contracts receivable (2) 43,112 4,107 Other long-term assets 2,216 2,310 Total contract assets $ 168,263 $ 85,244 (1) The unbilled contracts receivable increase relates primarily to a change in billing process in the three months ended March 31, 2022. This change has no impact on the Company’s cash flows. (2) The long-term unbilled contracts receivable increase relates primarily to the recognition of revenue from a multi-year contract with a customer in the three months ended March 31, 2022.
Schedule of Allowance for Credit Losses	The following table presents the activity in the allowance for credit losses for the three months ended March 31, 2022 and 2021 (in thousands): Three Months Ended March 31, 2022 Three Months Ended March 31, 2021 Accounts Receivable Unbilled Contracts Receivable Accounts Receivable Unbilled Contracts Receivable Beginning balance $ 3,102 $ 729 $ 7,336 $ 2,231 Provision for (reversal of) credit losses (180 ) (111 ) 1,142 123 Recoveries (38 ) — (591 ) — Charged-off/other adjustments 11 (76 ) (3,849 ) (1 ) 530 Balance at end of period $ 2,895 $ 542 $ 4,038 $ 2,884 (1) The charge off of accounts receivable in the first quarter of 2021 was primarily related to a customer whose account had been substantially reserved for credit losses in 2020 due to deteriorating financial condition and delinquent payment history.
Schedule of Revenue Recognized in Period	The following table presents additional revenue and contract disclosures (in thousands): Three Months Ended March 31, 2022 2021 Revenue recognized in the period from: Amounts included in deferred revenue at the beginning of the period $ 10,241 $ 10,712 Performance obligations satisfied in previous periods (true ups, licensee reporting adjustments and settlements)* $ 153 $ 19,863 *True ups represent the differences between the Company’s quarterly estimates of per-unit royalty revenue and actual production/sales-based royalties reported by licensees in the following period. Licensee reporting adjustments represent corrections or revisions to previously reported per-unit royalties by licensees, generally resulting from the Company’s inquiries or compliance audits. Settlements represent resolutions of litigation during the period for past royalties owed pursuant to expired or terminated IP license agreements.
Schedule of Remaining Performance Obligations	The Company's remaining revenue under contracts with performance obligations was as follows (in thousands) : As of March 31, 2022 December 31, 2021 Revenue from contracts with performance obligations expected to be satisfied in: 2022 (remaining 9 months) $ 130,163 $ 176,646 2023 155,635 153,746 2024 126,123 122,488 2025 112,594 110,703 2026 10,940 10,735 Thereafter 4,647 4,441 Total $ 540,102 $ 578,759

Composition of Certain Financ_2

Composition of Certain Financial Statement Captions (Tables)	3 Months Ended
	Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Schedule of Other Current Assets	Other current assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Prepaid income taxes $ 6,557 $ 6,103 Prepaid expenses 22,670 18,616 Inventory* 6,785 5,101 Other 6,725 6,639 $ 42,737 $ 36,459 *All inventory is finished goods.
Schedule of Property and Equipment, Net	Property and equipment, net, consisted of the following (in thousands): March 31, 2022 December 31, 2021 Equipment, furniture and other $ 84,897 $ 81,076 Building and improvements 18,331 18,331 Land 5,300 5,300 Leasehold improvements 25,607 25,535 134,135 130,242 Less: accumulated depreciation and amortization (74,884 ) (69,268 ) $ 59,251 $ 60,974
Schedule of Other Long Term Assets	Other long-term assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Long-term deferred tax assets $ 3,906 $ 3,758 Non-current income tax receivable 119,028 118,085 Other assets 27,707 26,122 $ 150,641 $ 147,965
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): March 31, 2022 December 31, 2021 Employee compensation and benefits $ 22,618 $ 42,075 Third-party royalties 4,470 4,428 Accrued expenses 29,885 38,089 Accrued severance 2,359 1,921 Current portion of operating lease liabilities 16,277 16,467 Other 23,931 7,725 $ 99,540 $ 110,705
Schedule of Other Long-Term Liabilities	Other long-term liabilities consisted of the following (in thousands): March 31, 2022 December 31, 2021 Long-term income tax payable $ 95,238 $ 91,614 Other 7,029 7,228 $ 102,267 $ 98,842
Schedule of Accumulated Other Comprehensive Loss	Accumulated other comprehensive loss consisted of the following (in thousands): March 31, 2022 December 31, 2021 Unrealized loss on available-for-sale debt securities, net of tax $ (243 ) $ (122 ) Foreign currency translation adjustment, net of tax (1,523 ) (630 ) $ (1,766 ) $ (752 )

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2022
Investments Debt And Equity Securities [Abstract]
Summary of Marketable Securities	The following is a summary of marketable securities at March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Estimated Fair Values Marketable securities Corporate bonds and notes $ 31,774 $ — $ (136 ) $ — $ 31,638 Commercial paper 64,867 1 (58 ) — 64,810 Total debt securities 96,641 1 (194 ) — 96,448 Money market funds 5,938 — — — 5,938 Total equity securities 5,938 — — — 5,938 Total marketable securities $ 102,579 $ 1 $ (194 ) $ — $ 102,386 Reported in: Cash and cash equivalents $ 49,666 Available-for-sale debt securities 52,720 Total marketable securities $ 102,386 December 31, 2021 Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit losses Estimated Fair Values Marketable securities Corporate bonds and notes $ 40,466 $ — $ (53 ) $ — $ 40,413 Commercial paper 49,609 — (18 ) — 49,591 Total debt securities 90,075 — (71 ) — 90,004 Money market funds 12,372 — — — 12,372 Total equity securities 12,372 — — — 12,372 Total marketable securities $ 102,447 $ — $ (71 ) $ — $ 102,376 Reported in: Cash and cash equivalents $ 41,842 Available-for-sale debt securities 60,534 Total marketable securities $ 102,376
Fair Value and Gross Unrealized Losses Related to Individual Available-for-Sale Debt Securities	The following table summarizes the fair value and gross unrealized losses related to individual AFS debt securities at March 31, 2022 and December 31, 2021, which have been in a continuous unrealized loss position, aggregated by investment category and length of time (in thousands): Less Than 12 Months 12 Months or More Total Fair Value March 31, 2022 Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Cash and Cash Equivalents AFS Debt Securities Corporate bonds and notes $ 18,212 $ (88 ) $ 11,926 $ (48 ) $ 30,138 $ (136 ) $ — $ 30,138 Commercial paper 56,564 (58 ) — — 56,564 (58 ) 35,482 21,082 Total $ 74,776 $ (146 ) $ 11,926 $ (48 ) $ 86,702 $ (194 ) $ 35,482 $ 51,220 Less Than 12 Months 12 Months or More Total Fair Value December 31, 2021 Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Cash and Cash Equivalents AFS Debt Securities Corporate bonds and notes $ 29,807 $ (45 ) $ 10,382 $ (8 ) $ 40,189 $ (53 ) $ — $ 40,189 Commercial paper 48,091 (18 ) — — 48,091 (18 ) 29,470 18,621 Total $ 77,898 $ (63 ) $ 10,382 $ (8 ) $ 88,280 $ (71 ) $ 29,470 $ 58,810
Estimated Fair Value of Marketable Debt Securities by Contractual Maturity	The estimated fair value of marketable debt securities by contractual maturity at March 31, 2022 is shown below (in thousands). Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without penalties. Estimated Fair Value Due in one year or less $ 48,599 Due in one to two years 4,121 Total $ 52,720

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value Assets Measured on Recurring Basis	The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of March 31, 2022 (in thousands): Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Marketable securities Money market funds - equity securities (1) $ 5,938 $ 5,938 $ — $ — Corporate bonds and notes - debt securities (2) 31,638 — 31,638 — Commercial paper - debt securities (3) 64,810 — 64,810 — Total Assets $ 102,386 $ 5,938 $ 96,448 $ — (1) Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet. (2) Reported as AFS debt securities in (3) Reported as cash and cash equivalents if purchased with an original maturity of three months or less at the date of purchase; otherwise reported as AFS debt securities in The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of December 31, 2021 (in thousands): Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets Marketable securities Money market funds - equity securities (1) $ 12,372 $ 10,372 $ 2,000 $ — Corporate bonds and notes - debt securities (2) 40,413 — 40,413 — Commercial paper - debt securities (3) 49,591 — 49,591 — Total Assets $ 102,376 $ 10,372 $ 92,004 $ — (1) Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet. (2) Reported as AFS debt securities in the Condensed Consolidated Balance Sheet. (3) Reported as cash and cash equivalents if purchased with an original maturity of three months or less at the date of purchase; otherwise reported as AFS debt securities in
Schedule of Carrying Amounts and Estimated Fair Values	The carrying amounts and estimated fair values are as follows (in thousands): March 31, 2022 December 31, 2021 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value Refinanced Term B Loans (1) $ 756,485 $ 745,138 $ 765,487 $ 764,530 Total long-term debt, net $ 756,485 $ 745,138 $ 765,487 $ 764,530 (1) Carrying amounts of long-term debt are net of unamortized debt discount and issuance costs of $23.1 million and $24.3 million as of March 31, 2022 and December 31, 2021, respectively. See “Note 9 – Debt ” for additional information.

Business Combinations (Tables)

Business Combinations (Tables)	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Schedule of Estimated Fair Value that Allocated to Assets and Liabilities	The following table sets forth the final purchase price allocation with no measure period adjustments identified ($ in thousands): Estimated Useful Life (years) Final Fair Value Other current assets $ 390 Property and equipment 9,223 Operating lease right-of-use assets 1,186 Identifiable intangible assets: Patents 10 5,000 Technology 6 3,260 Total identifiable intangible assets 8,260 Goodwill 4,059 Other long-term assets 115 Accrued liabilities (5,288 ) Noncurrent operating lease liabilities (545 ) Total purchase price $ 17,400

Goodwill and Identified Intan_2

Goodwill and Identified Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Changes to Carrying Value of Goodwill	The changes to the carrying value of goodwill from January 1, 2022 through March 31, 2022 are reflected below (in thousands): December 31, 2021 $ 851,088 Goodwill adjustment related to Mergers in prior periods (1) (988 ) March 31, 2022 (2) $ 850,100 (1) Reflects the correction of an error in the purchase price allocation for the Mergers to reduce goodwill and revenue. The error was not material to the current period financial statements or any prior periods. (2) The Company's reporting units include the IP Licensing segment and the Product segment (defined further in “Note 16 - Segment and Geographic Information ”). Of the carrying value of goodwill, approximately $322.3 million was allocated to the IP Licensing segment and approximately $527.8 million was allocated to the Product segment as of each of March 31, 2022 and December 31, 2021.
Identified Intangible Assets	Identified Intangible Assets Identified intangible assets consisted of the following (in thousands): Average March 31, 2022 December 31, 2021 Life (Years) Gross Assets Accumulated Amortization Net Gross Assets Accumulated Amortization Net Finite-lived intangible assets Acquired patents / core technology 3-10 $ 672,992 $ (238,788 ) $ 434,204 $ 672,872 $ (224,508 ) $ 448,364 Existing technology / content database 5-10 251,465 (211,712 ) 39,753 251,445 (206,934 ) 44,511 Customer contracts and related relationships 3-9 649,838 (379,519 ) 270,319 649,926 (360,543 ) 289,383 Trademarks/trade name 4-10 40,083 (27,079 ) 13,004 40,083 (25,825 ) 14,258 Non-competition agreements 1 2,231 (2,231 ) — 2,231 (2,231 ) — Total finite-lived intangible assets 1,616,609 (859,329 ) 757,280 1,616,557 (820,041 ) 796,516 Indefinite-lived intangible assets TiVo Tradename/trademarks N/A 21,400 — 21,400 21,400 — 21,400 Total intangible assets $ 1,638,009 $ (859,329 ) $ 778,680 $ 1,637,957 $ (820,041 ) $ 817,916
Estimated Future Amortization Expense	As of March 31, 2022, the estimated future amortization expense of total finite-lived intangible assets was as follows (in thousands): 2022 (remaining 9 months) $ 116,730 2023 145,084 2024 106,171 2025 81,716 2026 78,719 Thereafter 228,860 $ 757,280

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Outstanding Amounts of Debt	The outstanding amounts of debt were as follows (in thousands): March 31, 2022 December 31, 2021 Refinanced Term B Loans $ 779,625 $ 789,750 Unamortized debt discount and issuance costs (23,140 ) (24,263 ) 756,485 765,487 Less: current portion, net of debt discount and issuance costs (36,152 ) (36,095 ) Total long-term debt, net of current portion $ 720,333 $ 729,392
Summarize of Future Minimum Principal Payments for Long-term Debt	As of March 31, 2022, future minimum principal payments for long-term debt are summarized as follows (in thousands): 2022 (remaining 9 months) $ 30,375 2023 40,500 2024 40,500 2025 40,500 2026 40,500 Thereafter 587,250 Total $ 779,625

Net Income Per Share (Tables)

Net Income Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Income Per Share	The following table sets forth the computation of basic and diluted shares (in thousands): Three Months Ended March 31, 2022 March 31,2021 Denominator: Weighted average shares of common stock outstanding 103,679 104,940 Total common shares-basic 103,679 104,940 Effect of dilutive securities: Options 3 32 Restricted stock awards and units 1,650 2,804 Total common shares-diluted 105,332 107,776

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Stock Option Activity	A summary of the stock option activity is presented below (in thousands, except per share amounts): Options Outstanding Number of Shares Subject to Options Weighted Average Exercise Price Per Share Balance at December 31, 2021 447 $ 25.22 Options granted — $ — Options exercised (1 ) $ 17.60 Options canceled / forfeited / expired (22 ) $ 54.69 Balance at March 31, 2022 424 $ 23.64
Summary of Restricted Stock Awards and Units	Information with respect to outstanding restricted stock awards and units (including both time-based vesting and performance-based vesting) as of March 31, 2022 is as follows (in thousands, except per share amounts): Restricted Stock and Restricted Stock Units Number of Shares Subject to Time- based Vesting Number of Shares Subject to Performance- based Vesting Total Number of Shares Weighted Average Grant Date Fair Value Per Share Balance at December 31, 2021 6,815 1,525 8,340 $ 19.61 Awards and units granted 1,918 — 1,918 $ 17.38 Awards and units vested / earned (1,274 ) (335 ) (1,609 ) $ 20.87 Awards and units canceled / forfeited (339 ) (174 ) (513 ) $ 19.73 Balance at March 31, 2022 7,120 1,016 8,136 $ 18.83

Stock-Based Compensation Expe_2

Stock-Based Compensation Expense (Tables)	3 Months Ended
	Mar. 31, 2022
Effect of Recording Stock-Based Compensation Expense	The effect of recording stock-based compensation (“SBC”) expense for the three months ended March 31, 2022 and 2021 is as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Cost of revenue, excluding depreciation and amortization of intangible assets $ 628 $ 323 Research, development and other related costs 5,475 4,347 Selling, general and administrative 10,701 8,549 Total stock-based compensation expense 16,804 13,219 Tax effect on stock-based compensation expense (172 ) (154 ) Net effect on net income (loss) $ 16,632 $ 13,065
Stock-Based Compensation Expense Categorized by Equity Components	SBC expense categorized by various equity components for the three months ended March 31, 2022 and 2021 is summarized in the table below (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Restricted stock awards and units $ 15,220 $ 11,929 Employee stock purchase plan 1,584 1,271 Employee stock options — 19 Total stock-based compensation expense $ 16,804 $ 13,219
Employee Stock Purchase Plan
Schedule of Assumptions Used to Value Awards Granted	The following assumptions were used to value the ESPP shares for these grants: March 2022 September 2021 March 2021 Expected life (years) 2.0 2.0 2.0 Risk-free interest rate 1.3 % 0.2 % 0.1 % Dividend yield 1.1 % 0.9 % 1.2 % Expected volatility 48.5 % 52.0 % 52.0 %
Restricted Stock Units
Schedule of Assumptions Used to Value Awards Granted	The following assumptions were used to value the restricted stock units subject to market conditions granted during the period: March 2022* March 2021 Expected life (years) — 3.0 Risk-free interest rate — 0.3 % Dividend yield — 1.0 % Expected volatility — 47.9 % *There were no market-based restricted stock units granted in the three months ended March 31, 2022.

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of Operating Lease Costs	The components of operating lease costs were as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Fixed lease cost (1) $ 5,526 $ 5,466 Variable lease cost 1,274 1,365 Less: sublease income (2,106 ) (2,188 ) Total operating lease cost $ 4,694 $ 4,643 (1) Includes short-term leases, which were immaterial.
Schedule of Other Information Related to Leases	Other information related to leases was as follows (in thousands, except lease term and discount rate): Three Months Ended, March 31, 2022 March 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 5,585 $ 5,555 ROU assets obtained in exchange for new lease liabilities: Operating leases $ 1,908 $ — March 31, 2022 December 31, 2021 Weighted-average remaining lease term (years): Operating leases 4.2 4.4 Weighted-average discount rate: Operating leases 5.0 % 5.0 %
Schedule of Future Minimum Lease Payments and Related Lease Liabilities	Future minimum lease payments and related lease liabilities as of March 31, 2022 were as follows (in thousands): Operating Lease Payments (1) Sublease Income Net Operating Lease Payments 2022 (remaining 9 months) $ 14,479 $ (5,470 ) $ 9,009 2023 19,179 (7,618 ) 11,561 2024 17,253 (7,610 ) 9,643 2025 15,374 (7,386 ) 7,988 2026 6,586 (935 ) 5,651 Thereafter 3,244 — 3,244 Total lease payments 76,115 (29,019 ) 47,096 Less: imputed interest (7,908 ) — (7,908 ) Present value of lease liabilities: $ 68,207 $ (29,019 ) $ 39,188 Less: current obligations under leases (accrued liabilities) 16,277 Noncurrent operating lease liabilities $ 51,930 (1) Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes.

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	The following table sets forth the Company’s segment revenue, operating expenses and operating income for the three months ended March 31, 2022 and 2021 (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Revenue: IP Licensing segment $ 138,531 $ 98,014 Product segment 118,889 123,582 Total revenue 257,420 221,596 Operating expenses: IP Licensing segment 35,292 33,567 Product segment 97,511 108,563 Unallocated operating expenses (1) 71,648 69,067 Total operating expenses 204,451 211,197 Operating income: IP Licensing segment 103,239 64,447 Product segment 21,378 15,019 Unallocated operating expenses (1) (71,648 ) (69,067 ) Total operating income $ 52,969 $ 10,399 (1) Unallocated operating expenses consist primarily of selling, marketing, general and administrative expenses, such as administration, human resources, finance, information technology, corporate development and procurement. These expenses are not allocated because these amounts are not considered in evaluating the operating performance of the Company’s business segments.
Schedule of Geographic Revenue Information	The table below lists the geographic revenue for the periods indicated (in thousands): Three Months Ended March 31, 2022 March 31, 2021 U.S. $ 182,846 71 % $ 131,498 59 % Japan 18,884 7 26,444 12 South Korea 7,056 3 18,513 9 Europe and Middle East 13,020 5 16,422 7 Other 35,614 14 28,719 13 $ 257,420 100 % $ 221,596 100 %

The Company and Basis of Pres_2

The Company and Basis of Presentation - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022Patent$ / shares	Dec. 31, 2021$ / shares	Jun. 02, 2020$ / shares
Organization Consolidation And Presentation [Line Items]
Effective date of merger	Jun. 1, 2020
Common stock, par value (in dollars per share) | $ / shares	$ 0.001	$ 0.001	$ 0.001
Perceive Corporation
Organization Consolidation And Presentation [Line Items]
Ownership interest, percentage	80.00%
Minimum
Organization Consolidation And Presentation [Line Items]
Number of patents and applications | Patent	11,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details) - Accounting Standards Update 2021-08	Mar. 31, 2022
Summary of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted [true false]	true
Change in accounting principle accounting standards update adoption date	Jan. 1, 2022
Change in accounting principle, accounting standards update, immaterial effect [true false]	true

Revenue - Additional Informatio

Revenue - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022segmentRevenueModel
Revenue Recognition [Line Items]
Number of operating segments | segment	2
Number of revenue models used for company licenses | RevenueModel	3
Maximum
Revenue Recognition [Line Items]
Practical expedient, timing of revenue recognition differs from the timing of cash collection, period	1 year
Revenue recognition practical expedient amortization period	1 year
Practical expedient revenue expected to be recognized from unsatisfied performance obligations, duration	1 year

Revenue - Schedule of Revenue D

Revenue - Schedule of Revenue Disaggregated by Product Category/End Market (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue:	$ 257,420	$ 221,596
Product Revenue
Disaggregation of Revenue [Line Items]
Revenue:	118,889	123,582
IP Licensing Revenue
Disaggregation of Revenue [Line Items]
Revenue:	138,531	98,014
Pay TV | Product Revenue
Disaggregation of Revenue [Line Items]
Revenue:	64,155	63,743
Consumer Electronics | Product Revenue
Disaggregation of Revenue [Line Items]
Revenue:	28,091	31,105
Connected Car | Product Revenue
Disaggregation of Revenue [Line Items]
Revenue:	19,719	22,891
Media Platform | Product Revenue
Disaggregation of Revenue [Line Items]
Revenue:	$ 6,924	$ 5,843

Revenue - Schedule of Contract

Revenue - Schedule of Contract Assets (Details) - USD ($) $ in Thousands		Mar. 31, 2022	Dec. 31, 2021
Revenue From Contract With Customer [Abstract]
Unbilled contracts receivable	[1]	$ 121,778	$ 77,677
Other current assets		1,157	1,150
Long-term unbilled contracts receivable	[2]	43,112	4,107
Other long-term assets		2,216	2,310
Total contract assets		$ 168,263	$ 85,244
[1]	The unbilled contracts receivable increase relates primarily to a change in billing process in the three months ended March 31, 2022. This change has no impact on the Company’s cash flows.
[2]	The long-term unbilled contracts receivable increase relates primarily to the recognition of revenue from a multi-year contract with a customer in the three months ended March 31, 2022.

Revenue - Schedule of Allowance

Revenue - Schedule of Allowance for Credit Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accounts Receivable
Accounts Notes And Loans Receivable [Line Items]
Beginning balance	$ 3,102	$ 7,336
Provision for (reversal of) credit losses	(180)	1,142
Recoveries	(38)	(591)
Charged-off/other adjustments	11	(3,849)
Balance at end of period	2,895	4,038
Unbilled Contracts Receivable
Accounts Notes And Loans Receivable [Line Items]
Beginning balance	729	2,231
Provision for (reversal of) credit losses	(111)	123
Charged-off/other adjustments	(76)	530
Balance at end of period	$ 542	$ 2,884

Revenue - Schedule of Revenue R

Revenue - Schedule of Revenue Recognized in Period (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue From Contract With Customer [Abstract]
Amounts included in deferred revenue at the beginning of the period	$ 10,241	$ 10,712
Performance obligations satisfied in previous periods (true ups, licensee reporting adjustments and settlements)	$ 153	$ 19,863

Revenue - Schedule of Remaining

Revenue - Schedule of Remaining Performance Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 540,102	$ 578,759
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations		$ 176,646
Performance obligations expected to be satisfied, expected timing		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 130,163
Performance obligations expected to be satisfied, expected timing	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations		$ 153,746
Performance obligations expected to be satisfied, expected timing		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 155,635
Performance obligations expected to be satisfied, expected timing	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations		$ 122,488
Performance obligations expected to be satisfied, expected timing		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 126,123
Performance obligations expected to be satisfied, expected timing	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations		$ 110,703
Performance obligations expected to be satisfied, expected timing		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 112,594
Performance obligations expected to be satisfied, expected timing	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations		$ 10,735
Performance obligations expected to be satisfied, expected timing		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 10,940
Performance obligations expected to be satisfied, expected timing	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations		$ 4,441
Performance obligations expected to be satisfied, expected timing
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 4,647
Performance obligations expected to be satisfied, expected timing

Revenue - Schedule of Remaini_2

Revenue - Schedule of Remaining Performance Obligations (Details 1) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Revenue From Contract With Customer [Abstract]
Remaining performance obligations	$ 540,102	$ 578,759

Composition of Certain Financ_3

Composition of Certain Financial Statement Captions - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Prepaid income taxes	$ 6,557	$ 6,103
Prepaid expenses	22,670	18,616
Inventory	6,785	5,101
Other	6,725	6,639
Other current assets, total	$ 42,737	$ 36,459

Composition of Certain Financ_4

Composition of Certain Financial Statement Captions - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 134,135	$ 130,242
Less: accumulated depreciation and amortization	(74,884)	(69,268)
Property and equipment, net	59,251	60,974
Equipment, furniture and other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	84,897	81,076
Building and improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	18,331	18,331
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,300	5,300
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 25,607	$ 25,535

Composition of Certain Financ_5

Composition of Certain Financial Statement Captions - Schedule of Other Long Term Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Long-term deferred tax assets	$ 3,906	$ 3,758
Non-current income tax receivable	119,028	118,085
Other assets	27,707	26,122
Other long-term assets, total	$ 150,641	$ 147,965

Composition of Certain Financ_6

Composition of Certain Financial Statement Captions -Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Employee compensation and benefits	$ 22,618	$ 42,075
Third-party royalties	4,470	4,428
Accrued expenses	29,885	38,089
Accrued severance	2,359	1,921
Current portion of operating lease liabilities	$ 16,277	$ 16,467
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities, total	Accrued liabilities, total
Other	$ 23,931	$ 7,725
Accrued liabilities, total	$ 99,540	$ 110,705

Composition of Certain Financ_7

Composition of Certain Financial Statement Captions - Schedule of Other Long-Term Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Long-term income tax payable	$ 95,238	$ 91,614
Other	7,029	7,228
Other long-term liabilities, total	$ 102,267	$ 98,842

Composition of Certain Financ_8

Composition of Certain Financial Statement Captions - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Unrealized loss on available-for-sale debt securities, net of tax	$ (243)	$ (122)
Foreign currency translation adjustment, net of tax	(1,523)	(630)
Accumulated other comprehensive income	$ (1,766)	$ (752)

Financial Instruments - Summary

Financial Instruments - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Marketable Securities [Line Items]
Debt securities, Cost	$ 96,641	$ 90,075
Debt securities, Gross Unrealized Gains	1	0
Debt securities, Gross Unrealized Losses	(194)	(71)
Debt securities, Allowance for Credit Losses	0	0	$ 0
Debt securities, Estimated Fair Values	96,448	90,004
Equity securities, Cost	5,938	12,372
Equity securities, Gross Unrealized Gains	0	0
Equity securities, Gross Unrealized Losses	0	0
Equity securities, Allowance for Credit Losses	0	0
Equity securities, Estimated Fair Values	5,938	12,372
Marketable securities, Cost	102,579	102,447
Marketable securities, Gross Unrealized Gains	1	0
Marketable securities, Gross Unrealized Losses	(194)	(71)
Marketable securities, Allowance for Credit Losses	0	0
Marketable securities, Estimated Fair Values	102,386	102,376
Corporate bonds and notes
Marketable Securities [Line Items]
Debt securities, Cost	31,774	40,466
Debt securities, Gross Unrealized Gains	0	0
Debt securities, Gross Unrealized Losses	(136)	(53)
Debt securities, Allowance for Credit Losses	0	0
Debt securities, Estimated Fair Values	31,638	40,413
Commercial paper
Marketable Securities [Line Items]
Debt securities, Cost	64,867	49,609
Debt securities, Gross Unrealized Gains	1	0
Debt securities, Gross Unrealized Losses	(58)	(18)
Debt securities, Allowance for Credit Losses	0	0
Debt securities, Estimated Fair Values	64,810	49,591
Money market funds
Marketable Securities [Line Items]
Equity securities, Cost	5,938	12,372
Equity securities, Gross Unrealized Gains	0	0
Equity securities, Gross Unrealized Losses	0	0
Equity securities, Allowance for Credit Losses	0	0
Equity securities, Estimated Fair Values	5,938	12,372
Cash and cash equivalents
Marketable Securities [Line Items]
Marketable securities, Estimated Fair Values	49,666	41,842
Available-for-sale debt securities
Marketable Securities [Line Items]
Marketable securities, Estimated Fair Values	$ 52,720	$ 60,534

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Schedule Of Investments [Line Items]
Cash, cash equivalents and short -term investments	$ 266,800,000		$ 261,700,000
Unrealized losses net of tax on available-for-sale debt securities	200,000		100,000
Provision for credit losses related available for sale debt securities	0	$ 0	0
TiVo Merger | Non-marketable Equity Securities
Schedule Of Investments [Line Items]
Equity securities accounted for under equity method	4,700,000		4,800,000
Equity securities without a readily determinable fair value	100,000		100,000
Non-marketable equity securities, without a readily determinable fair value, impairments or adjustments	0	$ 0
Operating Accounts
Schedule Of Investments [Line Items]
Cash, cash equivalents and short -term investments	$ 164,400,000		$ 159,300,000

Financial Instruments - Fair Va

Financial Instruments - Fair Value and Gross Unrealized Losses Related to Individual Available-for-Sale Debt Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	$ 74,776	$ 77,898
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	(146)	(63)
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 months or more, Fair Value	11,926	10,382
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 months or more, Gross Unrealized Losses	(48)	(8)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	86,702	88,280
Available-for-sale Securities, Continuous Unrealized Loss Position, Gross Unrealized Losses	(194)	(71)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value, Cash and Cash Equivalents	35,482	29,470
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value, AFS Debt Securities	51,220	58,810
Corporate bonds and notes
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	18,212	29,807
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	(88)	(45)
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 months or more, Fair Value	11,926	10,382
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 months or more, Gross Unrealized Losses	(48)	(8)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	30,138	40,189
Available-for-sale Securities, Continuous Unrealized Loss Position, Gross Unrealized Losses	(136)	(53)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value, Cash and Cash Equivalents	0	0
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value, AFS Debt Securities	30,138	40,189
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value	56,564	48,091
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	(58)	(18)
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 months or more, Fair Value	0	0
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 months or more, Gross Unrealized Losses	0	0
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	56,564	48,091
Available-for-sale Securities, Continuous Unrealized Loss Position, Gross Unrealized Losses	(58)	(18)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value, Cash and Cash Equivalents	35,482	29,470
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value, AFS Debt Securities	$ 21,082	$ 18,621

Financial Instruments - Estimat

Financial Instruments - Estimated Fair Value of Marketable Debt Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Investments Debt And Equity Securities [Abstract]
Due in one year or less	$ 48,599
Due in one to two years	4,121
Total	$ 52,720	$ 60,534

Fair Value - Schedule of Fair V

Fair Value - Schedule of Fair Value Assets Measured on Recurring Basis (Details) - Recurring - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 102,386	$ 102,376
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,938	10,372
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	96,448	92,004
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,938	12,372
Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,938	10,372
Money market funds | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	2,000
Money market funds | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Corporate bonds and notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,638	40,413
Corporate bonds and notes | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Corporate bonds and notes | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,638	40,413
Corporate bonds and notes | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	64,810	49,591
Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Commercial paper | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	64,810	49,591
Commercial paper | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 0	$ 0

Fair Value - Schedule of Carryi

Fair Value - Schedule of Carrying Amounts and Estimated Fair Values (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total long-term debt, net - Carrying Amount	$ 756,485	$ 765,487
Recurring
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total long-term debt, net - Carrying Amount	756,485	765,487
Total long-term debt, net - Estimated Fair Value	745,138	764,530
Recurring | Refinanced Term B Loans
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total long-term debt, net - Carrying Amount	756,485	765,487
Total long-term debt, net - Estimated Fair Value	$ 745,138	$ 764,530

Fair Value - Schedule of Carr_2

Fair Value - Schedule of Carrying Amounts and Estimated Fair Values (Parenthetical) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Unamortized debt discount and issuance costs	$ 23,140	$ 24,263
Term B Loan Facility
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Unamortized debt discount and issuance costs	$ 23,100	$ 24,300

Business Combinations - Additio

Business Combinations - Additional Information (Details) $ in Thousands	May 31, 2021USD ($)
MobiTV
Business Acquisition [Line Items]
Purchase price	$ 17,400

Business Combinations - Schedul

Business Combinations - Schedule of Purchase Price Allocation (Details) - USD ($) $ in Thousands	May 31, 2021	Mar. 31, 2022	Dec. 31, 2021
Identifiable intangible assets:
Goodwill		$ 850,100	$ 851,088
MobiTV
Business Acquisition [Line Items]
Other current assets	$ 390
Property and equipment	9,223
Operating lease right-of-use assets	1,186
Identifiable intangible assets:
Total identifiable intangible assets	8,260
Goodwill	4,059
Other long-term assets	115
Accrued liabilities	(5,288)
Noncurrent operating lease liabilities	(545)
Total purchase price	$ 17,400
MobiTV | Patents
Business Acquisition [Line Items]
Estimated Useful Life (years)	10 years
Identifiable intangible assets:
Total identifiable intangible assets	$ 5,000
MobiTV | Technology
Business Acquisition [Line Items]
Estimated Useful Life (years)	6 years
Identifiable intangible assets:
Total identifiable intangible assets	$ 3,260

Goodwill and Identified Intan_3

Goodwill and Identified Intangible Assets - Summary of Changes to Carrying Value of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill, beginning	$ 851,088
Goodwill adjustment related to Mergers in prior periods	(988)
Goodwill, ending	$ 850,100

Goodwill and Identified Intan_4

Goodwill and Identified Intangible Assets - Summary of Changes to Carrying Value of Goodwill (Parenthetical) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Goodwill	$ 850,100	$ 851,088
IP Licensing Segment
Goodwill [Line Items]
Goodwill	322,300	322,300
Product Revenue
Goodwill [Line Items]
Goodwill	$ 527,800	$ 527,800

Goodwill and Identified Intan_5

Goodwill and Identified Intangible Assets - Identified Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 1,638,009	$ 1,637,957
Finite-lived intangible assets, Gross Assets	1,616,609	1,616,557
Finite-lived intangible assets, Accumulated Amortization	(859,329)	(820,041)
Intangible assets, net	778,680	817,916
Finite-lived intangible assets, Net	757,280	796,516
TiVo Tradename/trademarks
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Gross Assets	21,400	21,400
Indefinite-lived intangible assets, Net	21,400	21,400
Acquired patents / core technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Assets	672,992	672,872
Finite-lived intangible assets, Accumulated Amortization	(238,788)	(224,508)
Finite-lived intangible assets, Net	$ 434,204	448,364
Acquired patents / core technology | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	3 years
Acquired patents / core technology | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	10 years
Existing technology / content database
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Assets	$ 251,465	251,445
Finite-lived intangible assets, Accumulated Amortization	(211,712)	(206,934)
Finite-lived intangible assets, Net	$ 39,753	44,511
Existing technology / content database | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	5 years
Existing technology / content database | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	10 years
Customer contracts and related relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Assets	$ 649,838	649,926
Finite-lived intangible assets, Accumulated Amortization	(379,519)	(360,543)
Finite-lived intangible assets, Net	$ 270,319	289,383
Customer contracts and related relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	3 years
Customer contracts and related relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	9 years
Trademarks/trade name
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Assets	$ 40,083	40,083
Finite-lived intangible assets, Accumulated Amortization	(27,079)	(25,825)
Finite-lived intangible assets, Net	$ 13,004	14,258
Trademarks/trade name | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	4 years
Trademarks/trade name | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	10 years
Non-competition agreements
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Gross Assets	$ 2,231	2,231
Finite-lived intangible assets, Accumulated Amortization	$ (2,231)	$ (2,231)
Estimated Useful Life (years)	1 year

Goodwill and Identified Intan_6

Goodwill and Identified Intangible Assets - Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
2022 (remaining 9 months)	$ 116,730
2023	145,084
2024	106,171
2025	81,716
2026	78,719
Thereafter	228,860
Finite-lived intangible assets, Net	$ 757,280	$ 796,516

Debt - Schedule of Outstanding

Debt - Schedule of Outstanding Amounts of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Line Of Credit Facility [Line Items]
Long-term debt, Gross	$ 779,625
Unamortized debt discount and issuance costs	(23,140)	$ (24,263)
Long-term debt	756,485	765,487
Less: current portion, net of debt discount and issuance costs	(36,152)	(36,095)
Long-term debt, net	720,333	729,392
Refinanced Term B Loans
Line Of Credit Facility [Line Items]
Long-term debt, Gross	$ 779,625	$ 789,750

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($)	Jun. 08, 2021	Jun. 01, 2020	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2021
Line Of Credit Facility [Line Items]
Voluntary prepayment against the term loan			$ 10,125,000		$ 13,125,000
Unamortized debt discount and issuance costs			23,140,000			$ 24,263,000
Borrowings			756,485,000			$ 765,487,000
Interest expense			8,429,000		11,313,000
2020 Term B Loan Facility
Line Of Credit Facility [Line Items]
Debt Instrument Term		5 years
Borrowing capacity		$ 1,050,000,000
Loss on debt extinguishment				$ 8,000,000
Debt issuance cost			6,800,000
Unamortized debt discount and issuance costs			4,200,000
Debt issuance remaining third party fees				$ 2,600,000
Refinanced Term B Loans
Line Of Credit Facility [Line Items]
Borrowing capacity	$ 810,000,000
Voluntary prepayment against the term loan	$ 50,600,000
Debt instrument, prepayment premium	1.00%
Debt instrument, maturity date	Jun. 8, 2028
Interest expense			8,400,000		11,300,000
Amortized costs			1,100,000		$ 2,300,000
Refinanced Term B Loans | Base Rate
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	2.50%
Refinanced Term B Loans | Eurodollar, London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	3.50%
2021 Convertible Notes
Line Of Credit Facility [Line Items]
Unamortized debt discount and issuance costs			23,100,000
Borrowings			$ 779,600,000
Interest rate			4.20%

Debt - Summarize of Future Mini

Debt - Summarize of Future Minimum Principal Payments for Long-term Debt (Details) $ in Thousands	Mar. 31, 2022USD ($)
Debt Disclosure [Abstract]
2022 (remaining 9 months)	$ 30,375
2023	40,500
2024	40,500
2025	40,500
2026	40,500
Thereafter	587,250
Total	$ 779,625

Net Income Per Share - Computat

Net Income Per Share - Computation of Basic and Diluted Net Income Per Share (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Denominator:
Weighted average shares of common stock outstanding	103,679	104,940
Total common shares-basic (in shares)	103,679	104,940
Effect of dilutive securities:
Options (in shares)	3	32
Restricted stock awards and units (in shares)	1,650	2,804
Total common shares-diluted (in shares)	105,332	107,776

Net Income Per Share - Addition

Net Income Per Share - Additional Information (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Shares of common stock excluded from the computation of net income (loss) per share	3.6	1.1

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details)	Jun. 01, 2020	Mar. 31, 2022USD ($)shares	Mar. 31, 2021USD ($)shares	Dec. 31, 2021USD ($)$ / sharesshares	Mar. 31, 2022USD ($)$ / sharesshares	Apr. 22, 2021USD ($)	Jun. 12, 2020USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount | $						$ 100,000,000	$ 150,000,000
Treasury stock, total repurchase during period (in shares) | shares				9,000,000	10,000,000
Treasury stock, average price of share repurchased (in dollars per share) | $ / shares				$ 17.29	$ 17.24
Treasury stock, total cost of repurchased stock | $		$ 17,260,000	$ 25,007,000	$ 155,000,000	$ 172,200,000
Stock repurchase program, remaining amount available for repurchase | $		$ 77,800,000			$ 77,800,000
Tax withholding on restricted stock units (in shares) | shares		700,000	300,000
Tax withholding on restricted stock units | $		$ 11,100,000	$ 7,400,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period		24 months
Shares reserved for grant (in shares) | shares		100,000			100,000
Rolling expiration period		24 months
Maximum employee subscription rate		100.00%			100.00%
Purchase price of common stock, percent		85.00%
Maximum employee subscription amount | $		$ 25,000			$ 25,000
Performance Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance awards, percentage of grant available to vest		0.00%
Performance Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance awards, percentage of grant available to vest		200.00%
2020 EIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation full value awards counted against shares available for issuance ratio		1.5
Number of shares reserved for issuance | shares		8,000,000			8,000,000
Expiration period		10 years
Vesting period		4 years
2020 EIP | Time-based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		4 years
Assumed Plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	7 years
Vesting period	4 years
Assumed Plans | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
2020 EIP and Assumed Plans | Employee Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for grant (in shares) | shares		1,800,000			1,800,000

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Option Activity (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Number of Shares Subject to Options
Number of Shares, Beginning balance (shares) | shares	447
Number of Shares, Options exercised (shares) | shares	(1)
Number of Shares, Options canceled / forfeited / expired (shares) | shares	(22)
Number of Shares, Ending balance (shares) | shares	424
Weighted Average Exercise Price Per Share
Weighted Average Exercise Price Per Share, Beginning balance (USD per share) | $ / shares	$ 25.22
Weighted Average Exercise Price Per Share, Options exercised (USD per share) | $ / shares	17.60
Weighted Average Exercise Price Per Share, Options canceled / forfeited / expired (USD per share) | $ / shares	54.69
Weighted Average Exercise Price Per Share, Ending balance (USD per share) | $ / shares	$ 23.64

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Restricted Stock Awards and Units (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Time-Based Restricted Stock Award and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted stock awards and units, beginning balance (shares)	6,815
Restricted stock awards and units, granted (shares)	1,918
Restricted stock awards and units, vested / earned (shares)	(1,274)
Restricted stock awards and units, canceled / forfeited (shares)	(339)
Restricted stock awards and units, ending balance (shares)	7,120
Performance-Based Restricted Stock Award and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted stock awards and units, beginning balance (shares)	1,525
Restricted stock awards and units, vested / earned (shares)	(335)
Restricted stock awards and units, canceled / forfeited (shares)	(174)
Restricted stock awards and units, ending balance (shares)	1,016
Restricted Stock and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted stock awards and units, beginning balance (shares)	8,340
Restricted stock awards and units, granted (shares)	1,918
Restricted stock awards and units, vested / earned (shares)	(1,609)
Restricted stock awards and units, canceled / forfeited (shares)	(513)
Restricted stock awards and units, ending balance (shares)	8,136
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted average grant date fair value per share of restricted stock and units, beginning balance (USD per share) | $ / shares	$ 19.61
Weighted average grant date fair value per share of restricted stock and units, granted (USD per share) | $ / shares	17.38
Weighted average grant date fair value per share of restricted stock and units, vested / earned (USD per share) | $ / shares	20.87
Weighted average grant date fair value of restricted stock and units, canceled / forfeited (USD per share) | $ / shares	19.73
Weighted average grant date fair value per share of restricted stock and units, ending balance (USD per share) | $ / shares	$ 18.83

Stock-Based Compensation Expe_3

Stock-Based Compensation Expense - Effect of Recording Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 16,804	$ 13,219
Tax effect on stock-based compensation expense	(172)	(154)
Net effect on net income (loss)	16,632	13,065
Cost of revenue, excluding depreciation and amortization of intangible assets
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	628	323
Research, development and other related costs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	5,475	4,347
Selling, general and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 10,701	$ 8,549

Stock-Based Compensation Expe_4

Stock-Based Compensation Expense - Stock-Based Compensation Expense Categorized by Equity Components (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 16,804	$ 13,219
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	1,584	1,271
Employee Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		19
Restricted Stock Awards and Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 15,220	$ 11,929

Stock-Based Compensation Expe_5

Stock-Based Compensation Expense - Additional Information (Details) - USD ($) $ in Millions	Mar. 01, 2022	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, options granted		0	0
Separation Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, accelerated vesting	372,244
Incremental stock-based compensation		$ 2.2

Stock-Based Compensation Expe_6

Stock-Based Compensation Expense - Schedule of Assumptions Used to Value Awards Granted (Details)	1 Months Ended
	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life (in years)	0 years	2 years	2 years
Risk-free interest rate	1.30%	0.20%	0.10%
Dividend yield	1.10%	0.90%	1.20%
Expected volatility	48.50%	52.00%	52.00%
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected life (in years)	0 years		3 years
Risk-free interest rate			0.30%
Dividend yield			1.00%
Expected volatility			47.90%

Stock-Based Compensation Expe_7

Stock-Based Compensation Expense - Schedule of Assumptions Used to Value Awards Granted (Parenthetical) (Details) - shares	1 Months Ended	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, options granted		0	0
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, options granted	0

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 21,533	$ (4,015)
Effective tax rate (percent)	47.30%	(786.40%)
Income (loss) before taxes	$ 45,508	$ 511
U.S. federal tax rate	21.00%
Increase in gross unrecognized tax benefits	$ 3,600
Gross unrecognized tax benefits	244,000	228,700	$ 240,400
Unrecognized tax benefits that would impact the effective income tax rate	95,200	96,000
Interest and tax penalties related to unrecognized tax benefits	200	$ 600
Accrued interest and tax penalties related to unrecognized tax benefits	$ 3,100		$ 2,800

Leases - Additional Information

Leases - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022
Lessee Lease Description [Line Items]
Operating lease existence of option to extend	true
Operating lease description	The Company’s leases have remaining lease terms of one year to eight years, some of which may include options to extend the leases for five years or longer, and some of which may include options to terminate the leases within the next 6 years or less. Leases with an initial term of 12 months or less are not recorded on the balance sheets
Minimum
Lessee Lease Description [Line Items]
Remaining lease term	1 year
Lessee term of period to extend	5 years
Maximum
Lessee Lease Description [Line Items]
Remaining lease term	8 years

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Fixed lease cost	$ 5,526	$ 5,466
Variable lease cost	1,274	1,365
Less: sublease income	(2,106)	(2,188)
Total operating lease cost	$ 4,694	$ 4,643

Leases - Schedule of Other Info

Leases - Schedule of Other Information Related to Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Leases [Abstract]
Operating cash flows from operating leases	$ 5,585	$ 5,555
Operating lease, ROU assets obtained in exchange for new lease liabilities	$ 1,908
Operating leases, weighted average remaining lease term (years)	4 years 2 months 12 days		4 years 4 months 24 days
Operating leases, weighted average discount rate	5.00%		5.00%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments and Related Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Operating Lease Payments
2022 (remaining 9 months)	$ 14,479
2023	19,179
2024	17,253
2025	15,374
2026	6,586
Thereafter	3,244
Total lease payments	76,115
Less: imputed interest	(7,908)
Present value of lease liabilities:	68,207
Current portion of operating lease liabilities	16,277	$ 16,467
Noncurrent operating lease liabilities	51,930	$ 54,658
Sublease Income
2022 (remaining 9 months)	(5,470)
2023	(7,618)
2024	(7,610)
2025	(7,386)
2026	(935)
Total lease payments	(29,019)
Present value of lease liabilities:	(29,019)
Net Operating Lease Payments
2022 (remaining 9 months)	9,009
2023	11,561
2024	9,643
2025	7,988
2026	5,651
Thereafter	3,244
Total lease payments	47,096
Less: imputed interest	(7,908)
Present value of lease liabilities:	$ 39,188

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Commitments And Contingencies Disclosure [Line Items]
Purchase commitments	$ 116,600
Accrued liabilities	99,540	$ 110,705
Inventory
Commitments And Contingencies Disclosure [Line Items]
Purchase commitments	9,800
Accrued liabilities	$ 2,900

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022segmentCustomer	Mar. 31, 2021Customer	Dec. 31, 2021Customer
Segment Reporting [Abstract]
Number of principal businesses segment | segment	2
Number of customers more than 10% of revenue	1	0
Number of customers more than 10% of accounts receivable	1		1

Segment and Geographic Inform_4

Segment and Geographic Information - Schedule of Segment Reporting Information by Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Total revenue	$ 257,420	$ 221,596
Total operating expenses	204,451	211,197
Operating income	52,969	10,399
Operating Segments | Product Revenue
Segment Reporting Information [Line Items]
Total revenue	118,889	123,582
Total operating expenses	97,511	108,563
Operating income	21,378	15,019
Operating Segments | IP Licensing Segment
Segment Reporting Information [Line Items]
Total revenue	138,531	98,014
Total operating expenses	35,292	33,567
Operating income	103,239	64,447
Unallocated Operating Expenses
Segment Reporting Information [Line Items]
Total operating expenses	71,648	69,067
Operating income	$ (71,648)	$ (69,067)

Segment and Geographic Inform_5

Segment and Geographic Information - Schedule of Geographic Revenue Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Foreign revenues	$ 257,420	$ 221,596
Total Revenue | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage (or more)	100.00%	100.00%
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Foreign revenues	$ 182,846	$ 131,498
U.S. | Total Revenue | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage (or more)	71.00%	59.00%
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Foreign revenues	$ 18,884	$ 26,444
Japan | Total Revenue | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage (or more)	7.00%	12.00%
South Korea
Revenues from External Customers and Long-Lived Assets [Line Items]
Foreign revenues	$ 7,056	$ 18,513
South Korea | Total Revenue | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage (or more)	3.00%	9.00%
Europe and Middle East
Revenues from External Customers and Long-Lived Assets [Line Items]
Foreign revenues	$ 13,020	$ 16,422
Europe and Middle East | Total Revenue | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage (or more)	5.00%	7.00%
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Foreign revenues	$ 35,614	$ 28,719
Other | Total Revenue | Geographic Concentration Risk
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage (or more)	14.00%	13.00%

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Subsequent Event	Apr. 29, 2022$ / sharesshares
Subsequent Event [Line Items]
Cash dividends declared per share (in dollars per share) | $ / shares	$ 0.05
Dividends declaration date	Apr. 29, 2022
Dividends payable date	Jun. 21, 2022
Dividends record date	May 31, 2022
Amendment to 2020 EIP
Subsequent Event [Line Items]
Number of additional shares added to share reserve	8,800,000
Amendment to 2020 ESPP
Subsequent Event [Line Items]
Number of additional shares added to share reserve	6,000,000